Brendan C. Visser, MD

4.8/5

54 Patient Ratings

263 Patient Reviews

Brendan C. Visser, MD

Hepatobiliary surgeon, Pancreatic surgeon, Surgeon

Professor of Surgery (General Surgery)

View Professional Summary

Additional Languages Spoken:

Spanish

Insurance Coverage

Online Second Opinion Program

Resources for Referring Physicians

Biography

Dr. Visser is a native of San Francisco, the youngest of eight children. He attended Deep Springs College in Eastern California and then went on to earn his BS at Cornell University in Ithaca NY. After receiving his MD degree at the University of California - San Francisco, he stayed at UCSF for his residency training in general surgery. He then completed specialized fellowship training in hepatobiliary and pancreatic surgery (also called HPB surgery) at the University of Edinburgh in Ediburgh, UK. Dr. Visser is board certified in general surgery by the American Board of Surgery. His principle practice is at Stanford Hospital and the Stanford Cancer Center.

Dr. Visser is the section chief of Hepato-Pancreato-Biliary (HPB) in the division of general surgery, department of surgery at Stanford. He is the program director for the Stanford Hepatopancreatobiliary (HPB) Surgery fellowship program and is actively involved in the General Surgery training program. Dr. Visser was honored in 2011 with the John Collins Memorial Teaching Award, an annual faculty recognition selected by the entire body of general surgery residents. He also received the Best Rotation Award in 2015 and 2020, which is selected by Stanford chief and senior residents in general surgery. He is the Medical Director of the GI Cancer Care Program at the Stanford Cancer Center.

View Full Biography

Professional Summary

Education & Certifications

Residency: University of California San Francisco (2005) CA
Medical Education: University of California San Francisco (1999) CA
Fellowship: University of Edinburgh; Edinburgh Royal (2006)
- Board Certification: American Board of Surgery, General Surgery (2006)
- MD, Univ. of Calif., San Francisco, Medicine (1999)
- Resident, Univ. Of Calif., San Francisco, General Surgery (2005)
- Fellow, Univ. of Edinburgh, UK, Hepatobiliary/Pancreatic Surgery (2006)

View More Education & Certifications

Honors & Awards

AHPBA Gazi Zibari Global Outreach Humanitarian Award Recipient, The Americas Hepato-Pancreato-Biliary Association (2020)
Best Rotation Award: Senior Residents 2020, Stanford General Surgery Residency (2019-2020)
Best Rotation Award: Stanford Chief Residents 2015, Stanford General Surgery Residency (2014-2015)
- John Collins Memorial Teaching Award, Annual faculty teaching award selected by entire body of general surgery residents (2010-2011)
- Malinda S. Mitchell Award for Quality and Service, Stanford Health Care (2018)

View More Honors & Awards

Memberships

Member, Board of Directors, Fellowship Council (2019 - Present)
Chair, HPB Fellowship Program Directors Committee, Americas Hepatopancreticobiliary Association (AHPBA) (2018 - Present)
Chair, Training & Education Committee, International Hepatopancreatobiliary Association (IHPBA) (2015 - Present)
- Editorial Board, HPB (2011 - Present)

View More Memberships

Administrative Appointments

Medical Director, Gastrointestinal Cancer Care Program, Stanford Cancer Center (2015 - Present)
Program Director, HPB Surgery Fellowship, Division of General Surgery, Stanford Medicine (2013 - Present)
Section Chief, HPB Surgery, Division of General Surgery, Stanford Medicine (2023 - Present)

Publications

Safety and timing of nonobstetric abdominal surgery in pregnancy
Visser, B. C., Glasgow, R. E., Mulvihill, K. K., & Mulvihill, S. J. (2001). Safety and timing of nonobstetric abdominal surgery in pregnancy. DIGESTIVE SURGERY, 18(5), 409–417.
Adjuvant and neoadjuvant therapy for esophageal cancer: a critical reappraisal
Visser, B. C., Venook, A. P., & Patti, M. G. (2003). Adjuvant and neoadjuvant therapy for esophageal cancer: a critical reappraisal. SURGICAL ONCOLOGY-OXFORD, 12(1), 1–7.
Diagnostic imaging of cystic pancreatic neoplasms
Visser, B. C., Muthusamay, V. R., Mulvihill, S. J., & Coakley, F. (2004). Diagnostic imaging of cystic pancreatic neoplasms. SURGICAL ONCOLOGY-OXFORD, 13(1), 27–39.
- Congenital choledochal cysts in adults
  Visser, B. C., Suh, I., Way, L. W., & Kang, S. M. (2004). Congenital choledochal cysts in adults. ARCHIVES OF SURGERY, 139(8), 855–860.
- The influence of portoenterostomy on transplantation for biliary atresia
  Visser, B. C., Suh, I., Hirose, S., Rosenthal, P., LEE, H., Roberts, J. P., & Hirose, R. (2004). The influence of portoenterostomy on transplantation for biliary atresia. LIVER TRANSPLANTATION, 10(10), 1279–1286.
- Characterization of cystic pancreatic masses: Relative accuracy of CT and MRI
  Visser, B. C., Yeh, B. M., Qayyum, A., Way, L. W., McCulloch, C. E., & Coakley, F. V. (2007). Characterization of cystic pancreatic masses: Relative accuracy of CT and MRI. AMERICAN JOURNAL OF ROENTGENOLOGY, 189(3), 648–656.
- Open cholecystectomy in the laparoendoscopic era
  Visser, B. C., Parks, R. W., & Garden, O. J. (2008). Open cholecystectomy in the laparoendoscopic era. AMERICAN JOURNAL OF SURGERY, 195(1), 108–14.
- Diagnostic evaluation of cystic pancreatic lesions
  Visser, B. C., Muthusamy, V. R., Yeh, B. M., Coakley, F. V., & Way, L. W. (2008). Diagnostic evaluation of cystic pancreatic lesions. HPB, 10(1), 63–69.
- A NOVEL PRKAR1A MUTATION ASSOCIATED WITH PRIMARY PIGMENTED NODULAR ADRENOCORTICAL DISEASE AND THE CARNEY COMPLEX
  Peck, M. C., Visser, B. C., Norton, J. A., Pasche, L., & Katznelson, L. (2010). A NOVEL PRKAR1A MUTATION ASSOCIATED WITH PRIMARY PIGMENTED NODULAR ADRENOCORTICAL DISEASE AND THE CARNEY COMPLEX. ENDOCRINE PRACTICE, 16(2), 198–204.
- Death After Colectomy It's Later Than We Think
  Visser, B. C., Keegan, H., Martin, M., & Wren, S. M. (2009). Death After Colectomy It's Later Than We Think. ARCHIVES OF SURGERY, 144(11), 1021–27.
- Comparison of Intensity-Modulated Radiotherapy and 3-Dimensional Conformal Radiotherapy as Adjuvant Therapy for Gastric Cancer
  Minn, A. Y., Hsu, A., La, T., Kunz, P., Fisher, G. A., Ford, J. M., … Chang, D. T. (2010). Comparison of Intensity-Modulated Radiotherapy and 3-Dimensional Conformal Radiotherapy as Adjuvant Therapy for Gastric Cancer. CANCER. CHICAGO,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL: JOHN WILEY & SONS INC.
- Expression of p16(INK4A) But Not Hypoxia Markers or Poly Adenosine Diphosphate-Ribose Polymerase Is Associated With Improved Survival in Patients With Pancreatic Adenocarcinoma
  Chang, D. T., Chapman, C. H., Norton, J. A., Visser, B., Fisher, G. A., Kunz, P., … Pai, R. K. (2010). Expression of p16(INK4A) But Not Hypoxia Markers or Poly Adenosine Diphosphate-Ribose Polymerase Is Associated With Improved Survival in Patients With Pancreatic Adenocarcinoma. CANCER. CHICAGO,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL: WILEY-BLACKWELL.
- Predictors of Surgical Intervention for Hepatocellular Carcinoma
  Zak, Y., Rhoads, K. F., & Visser, B. C. (2011). Predictors of Surgical Intervention for Hepatocellular Carcinoma. ARCHIVES OF SURGERY, 146(7), 778–84.
- Ruptured Biliary Cystadenoma Managed by Angiographic Embolization and Interval Partial Hepatectomy
  Ghole, S. A., Bakhtary, S., Staudenmayer, K., Sze, D. Y., Pai, R. K., Visser, B. C., … Poultsides, G. A. (2011). Ruptured Biliary Cystadenoma Managed by Angiographic Embolization and Interval Partial Hepatectomy. DIGESTIVE DISEASES AND SCIENCES, 56(7), 1949–53.
- Pancreatic Endocrine Tumors With Major Vascular Abutment, Involvement, or Encasement and Indication for Resection
  Norton, J. A., Harris, E. J., Chen, Y., Visser, B. C., Poultsides, G. A., Kunz, P. C., … Jensen, R. T. (2011). Pancreatic Endocrine Tumors With Major Vascular Abutment, Involvement, or Encasement and Indication for Resection. ARCHIVES OF SURGERY, 146(6), 724–32.
- Adult Intestinal Malrotation: When Things Turn the Wrong Way
  Palmer, O. P., Rhee, H. H., Park, W. G., & Visser, B. C. (2012). Adult Intestinal Malrotation: When Things Turn the Wrong Way. DIGESTIVE DISEASES AND SCIENCES, 57(2), 284–87.
- Single-cell dissection of transcriptional heterogeneity in human colon tumors
  Dalerba, P., Kalisky, T., Sahoo, D., Rajendran, P. S., Rothenberg, M. E., Leyrat, A. A., … Quake, S. R. (2011). Single-cell dissection of transcriptional heterogeneity in human colon tumors. NATURE BIOTECHNOLOGY, 29(12), 1120–U11.
- Abdominal Mass, Anemia, Diabetes Mellitus, and Necrolytic Migratory Erythema
  Qadan, M., Visser, B., Kim, J., Pai, R., & Triadafilopoulos, G. (2012). Abdominal Mass, Anemia, Diabetes Mellitus, and Necrolytic Migratory Erythema. DIGESTIVE DISEASES AND SCIENCES, 57(6), 1465–68.
- Sump Syndrome as a Complication of Choledochoduodenostomy
  Qadan, M., Clarke, S., Morrow, E., Triadafilopoulos, G., & Visser, B. (2012). Sump Syndrome as a Complication of Choledochoduodenostomy. DIGESTIVE DISEASES AND SCIENCES, 57(8), 2011–15.
- Video-assisted thoracoscopic transdiaphragmatic liver resection for hepatocellular carcinoma
  Cloyd, J. M., & Visser, B. C. (2012). Video-assisted thoracoscopic transdiaphragmatic liver resection for hepatocellular carcinoma. SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 26(6), 1772–76.
- Intensity-Modulated Radiotherapy for Pancreatic Adenocarcinoma
  Abelson, J. A., Murphy, J. D., Minn, A. Y., Chung, M., Fisher, G. A., Ford, J. M., … Chang, D. T. (2012). Intensity-Modulated Radiotherapy for Pancreatic Adenocarcinoma. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. CHICAGO,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL,IL: ELSEVIER SCIENCE INC.
- Diagnostic accuracy of cyst fluid amphiregulin in pancreatic cysts
  Tun, M. T., Pai, R. K., Kwok, S., Dong, A., Gupta, A., Visser, B. C., … Park, W. G. (2012). Diagnostic accuracy of cyst fluid amphiregulin in pancreatic cysts. BMC GASTROENTEROLOGY, 12.
- Preoperative embolization of replaced right hepatic artery prior to pancreaticoduodenectomy
  Cloyd, J. M., Chandra, V., Louie, J. D., Rao, S., & Visser, B. C. (2012). Preoperative embolization of replaced right hepatic artery prior to pancreaticoduodenectomy. JOURNAL OF SURGICAL ONCOLOGY, 106(4), 509–12.
- Pancreatic Neuroendocrine Tumors: Radiographic Calcifications Correlate with Grade and Metastasis
  Poultsides, G. A., Huang, L. C., Chen, Y., Visser, B. C., Pai, R. K., Jeffrey, R. B., … Norton, J. A. (2012). Pancreatic Neuroendocrine Tumors: Radiographic Calcifications Correlate with Grade and Metastasis. ANNALS OF SURGICAL ONCOLOGY, 19(7), 2295–2303.
- Changes in spleen volume after resection of hepatic colorectal metastases
  Jacobs, K. E., Visser, B. C., & Gayer, G. (2012). Changes in spleen volume after resection of hepatic colorectal metastases. CLINICAL RADIOLOGY, 67(10), 982–87.
- The Epidemiology of Idiopathic Acute Pancreatitis, Analysis of the Nationwide Inpatient Sample From 1998 to 2007
  Chen, Y., Zak, Y., Hernandez-Boussard, T., Park, W., & Visser, B. C. (2013). The Epidemiology of Idiopathic Acute Pancreatitis, Analysis of the Nationwide Inpatient Sample From 1998 to 2007. PANCREAS, 42(1), 1–5.
- Failure to comply with NCCN guidelines for the management of pancreatic cancer compromises outcomes
  Visser, B. C., Ma, Y., Zak, Y., Poultsides, G. A., Norton, J. A., & Rhoads, K. F. (2012). Failure to comply with NCCN guidelines for the management of pancreatic cancer compromises outcomes. HPB, 14(8), 539–47.
- Lymph Nodes and Survival in Pancreatic Neuroendocrine Tumors
  Krampitz, G. W., Norton, J. A., Poultsides, G. A., Visser, B. C., Sun, L., & Jensen, R. T. (2012). Lymph Nodes and Survival in Pancreatic Neuroendocrine Tumors. ARCHIVES OF SURGERY, 147(9), 820–27.
- Seventh Edition (2010) of the AJCC/UICC Staging System for Gastric Adenocarcinoma: Is there Room for Improvement?
  Patel, M. I., Rhoads, K. F., Ma, Y., Ford, J. M., Visser, B. C., Kunz, P. L., … Poultsides, G. A. (2013). Seventh Edition (2010) of the AJCC/UICC Staging System for Gastric Adenocarcinoma: Is there Room for Improvement? ANNALS OF SURGICAL ONCOLOGY, 20(5), 1631–38.
- Neoadjuvant Imatinib for Borderline Resectable GIST
  Koontz, M. Z., Visser, B. M., & Kunz, P. L. (2012). Neoadjuvant Imatinib for Borderline Resectable GIST. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 10(12), 1477–82.
- Hospital readmission after a pancreaticoduodenectomy: an emerging quality metric?
  Kastenberg, Z. J., Morton, J. M., Visser, B. C., Norton, J. A., & Poultsides, G. A. (2013). Hospital readmission after a pancreaticoduodenectomy: an emerging quality metric? HPB, 15(2), 142–48.
- Complete resection of a rare intrahepatic variant of a choledochal cyst
  Salles, A., Kastenberg, Z. J., Wall, J. K., Visser, B. C., & Bruzoni, M. (2013). Complete resection of a rare intrahepatic variant of a choledochal cyst. JOURNAL OF PEDIATRIC SURGERY, 48(3), 652–54.
- Metabolomic-derived novel cyst fluid biomarkers for pancreatic cysts: glucose and kynurenine.
  Park, W. G., Wu, M., Bowen, R., Zheng, M., Fitch, W. L., Pai, R. K., … Peltz, G. (2013). Metabolomic-derived novel cyst fluid biomarkers for pancreatic cysts: glucose and kynurenine. Gastrointestinal Endoscopy, 78(2), 295–302 e2.
- Diagnostic Utility of Metabolomic-Derived Biomarkers for Pancreatic Cysts
  Park, W. G., Wu, M., Bowen, R., Zheng, M., Fitch, W. L., Pai, R. K., … Peltz, G. (2012). Diagnostic Utility of Metabolomic-Derived Biomarkers for Pancreatic Cysts. PANCREAS, 41(8), 1394–94.
- Gallstone pancreatitis: why not cholecystectomy?
  Worhunsky, D. J., & Visser, B. C. (2013). Gallstone pancreatitis: why not cholecystectomy? JAMA Surgery, 148(9), 872-?
- Colorectal cancer diagnostics: biomarkers, cell-free DNA, circulating tumor cells and defining heterogeneous populations by single-cell analysis.
  Kin, C., Kidess, E., Poultsides, G. A., Visser, B. C., & Jeffrey, S. S. (2013). Colorectal cancer diagnostics: biomarkers, cell-free DNA, circulating tumor cells and defining heterogeneous populations by single-cell analysis. Expert Review of Molecular Diagnostics, 13(6), 581–99.
- Development of a transillumination infrared modality for differential vasoactive optical imaging
  Dixit, S. S., Kim, H., Visser, B., & Faris, G. W. (2009). Development of a transillumination infrared modality for differential vasoactive optical imaging. APPLIED OPTICS, 48(10), D178–D186.
- Reassessment of the Current American Joint Committee on Cancer Staging System for Pancreatic Neuroendocrine Tumors
  Qadan, M., Ma, Y., Visser, B. C., Kunz, P. L., Fisher, G. A., Norton, J. A., & Poultsides, G. A. (2014). Reassessment of the Current American Joint Committee on Cancer Staging System for Pancreatic Neuroendocrine Tumors. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 218(2), 188–95.
- Does chronic kidney disease affect outcomes after major abdominal surgery? Results from the national surgical quality improvement program.
  Cloyd, J. M., Ma, Y., Morton, J. M., Kurella Tamura, M., Poultsides, G. A., & Visser, B. C. (2014). Does chronic kidney disease affect outcomes after major abdominal surgery? Results from the national surgical quality improvement program. Journal of Gastrointestinal Surgery , 18(3), 605–12.
- Pancreatic neuroendocrine tumours: hypoenhancement on arterial phase computed tomography predicts biological aggressiveness.
  Worhunsky, D. J., Krampitz, G. W., Poullos, P. D., Visser, B. C., Kunz, P. L., Fisher, G. A., … Poultsides, G. A. (2014). Pancreatic neuroendocrine tumours: hypoenhancement on arterial phase computed tomography predicts biological aggressiveness. HPB , 16(4), 304–11.
- Postoperative serum amylase predicts pancreatic fistula formation following pancreaticoduodenectomy.
  Cloyd, J. M., Kastenberg, Z. J., Visser, B. C., Poultsides, G. A., & Norton, J. A. (2014). Postoperative serum amylase predicts pancreatic fistula formation following pancreaticoduodenectomy. Journal of Gastrointestinal Surgery , 18(2), 348–53.
- Locally advanced gastric cancer complicated by mesenteric invasion and intestinal malrotation.
  Huang, R. J., Visser, B. C., Chen, A. M., & Ladabaum, U. (2014). Locally advanced gastric cancer complicated by mesenteric invasion and intestinal malrotation. Digestive Diseases and Sciences, 59(2), 267–69.
- Man with hypoechoic lesion abutting the pancreas.
  Krampitz, G. W., Mills, A. M., & Visser, B. C. (2014). Man with hypoechoic lesion abutting the pancreas. JAMA Surgery, 149(4), 393–94.
- Getting the dead out: modern treatment strategies for necrotizing pancreatitis.
  Dua, M. M., Worhunsky, D. J., Amin, S., Louie, J. D., Park, W. G., Triadafilopoulos, G., & Visser, B. C. (2014). Getting the dead out: modern treatment strategies for necrotizing pancreatitis. Digestive Diseases and Sciences, 59(9), 2069–75.
- Metabolomic-derived novel cyst fluid biomarkers for pancreatic cysts: glucose and kynurenine
  Park, W. G., Wu, M., Bowen, R., Zheng, M., Fitch, W. L., Pai, R. K., … Peltz, G. (2013). Metabolomic-derived novel cyst fluid biomarkers for pancreatic cysts: glucose and kynurenine. GASTROINTESTINAL ENDOSCOPY, 78(2), 295-?
- Laparoscopic spleen-preserving distal pancreatectomy: the technique must suit the lesion.
  Worhunsky, D. J., Zak, Y., Dua, M. M., Poultsides, G. A., Norton, J. A., & Visser, B. C. (2014). Laparoscopic spleen-preserving distal pancreatectomy: the technique must suit the lesion. Journal of Gastrointestinal Surgery , 18(8), 1445–51.
- Early vein reconstruction and right-to-left dissection for left-sided pancreatic tumors with portal vein occlusion.
  Cloyd, J. M., Dua, M. M., & Visser, B. C. (2014). Early vein reconstruction and right-to-left dissection for left-sided pancreatic tumors with portal vein occlusion. Journal of Gastrointestinal Surgery , 18(11), 2034–37.
- Non-MalIg(G4)nant Biliary Obstruction: When the Pill Is Mightier than the Knife
  Dua, M. M., Qadan, M., Lutchman, G. A., Park, W. G., Triadafilopoulos, G., & Visser, B. C. (2015). Non-MalIg(G4)nant Biliary Obstruction: When the Pill Is Mightier than the Knife. DIGESTIVE DISEASES AND SCIENCES, 60(5), 1178–82.
- More with Less: Pancreas-Preserving Total Duodenectomy
  Qadan, M., Dua, M., Worhunsky, D., Triadafilopoulos, G., & Visser, B. (2015). More with Less: Pancreas-Preserving Total Duodenectomy. DIGESTIVE DISEASES AND SCIENCES, 60(6), 1565–68.
- Laparoscopic Transgastric Necrosectomy for the Management of Pancreatic Necrosis
  Worhunsky, D. J., Qadan, M., Dua, M. M., Park, W. G., Poultsides, G. A., Norton, J. A., & Visser, B. C. (2014). Laparoscopic Transgastric Necrosectomy for the Management of Pancreatic Necrosis. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 219(4), 735–43.
- Cardiac metastases and tumor embolization: A rare sequelae of primary undifferentiated liver sarcoma.
  Dua, M. M., Cloyd, J. M., Haddad, F., Beygui, R. E., Norton, J. A., & Visser, B. C. (2014). Cardiac metastases and tumor embolization: A rare sequelae of primary undifferentiated liver sarcoma. International Journal of Surgery Case Reports, 5(12), 927–31.
- Extracorporeal Pringle for laparoscopic liver resection
  Dua, M. M., Worhunsky, D. J., Hwa, K., Poultsides, G. A., Norton, J. A., & Visser, B. C. (2015). Extracorporeal Pringle for laparoscopic liver resection. SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 29(6), 1348–55.
- Single-versus Multifraction Stereotactic Body Radiation Therapy for Pancreatic Adenocarcinoma: Outcomes and Toxicity
  Pollom, E. L., Alagappan, M., von Eyben, R., Kunz, P. L., Fisher, G. A., Ford, J. A., … Chang, D. T. (2014). Single-versus Multifraction Stereotactic Body Radiation Therapy for Pancreatic Adenocarcinoma: Outcomes and Toxicity. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 90(4), 918–25.
- Early Vein Reconstruction and Right-to-Left Dissection for Left-Sided Pancreatic Tumors with Portal Vein Occlusion
  Cloyd, J. M., Dua, M. M., & Visser, B. C. (2014). Early Vein Reconstruction and Right-to-Left Dissection for Left-Sided Pancreatic Tumors with Portal Vein Occlusion. JOURNAL OF GASTROINTESTINAL SURGERY, 18(11), 2034–37.
- Does the extent of resection impact survival for duodenal adenocarcinoma? Analysis of 1,611 cases.
  Cloyd, J. M., Norton, J. A., Visser, B. C., & Poultsides, G. A. (2015). Does the extent of resection impact survival for duodenal adenocarcinoma? Analysis of 1,611 cases. Annals of Surgical Oncology, 22(2), 573–80.
- Mutation profiling of tumor DNA from plasma and tumor tissue of colorectal cancer patients with a novel, high-sensitivity multiplexed mutation detection platform
  Kidess, E., Heirich, K., Wiggin, M., Vysotskaia, V., Visser, B. C., Marziali, A., … Poultsides, G. A. (2015). Mutation profiling of tumor DNA from plasma and tumor tissue of colorectal cancer patients with a novel, high-sensitivity multiplexed mutation detection platform. ONCOTARGET, 6(4), 2549–61.
- Compliance With Gastric Cancer Guidelines is Associated With Improved Outcomes.
  Worhunsky, D. J., Ma, Y., Zak, Y., Poultsides, G. A., Norton, J. A., Rhoads, K. F., & Visser, B. C. (2015). Compliance With Gastric Cancer Guidelines is Associated With Improved Outcomes. Journal of the National Comprehensive Cancer Network , 13(3), 319–25.
- Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing.
  Kurtz, D. M., Green, M. R., Bratman, S. V., Scherer, F., Liu, C. L., Kunder, C. A., … Alizadeh, A. A. (2015). Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing. Blood, 125(24), 3679–87.
- Cyst Fluid Glucose is Rapidly Feasible and Accurate in Diagnosing Mucinous Pancreatic Cysts.
  Zikos, T., Pham, K., Bowen, R., Chen, A. M., Banerjee, S., Friedland, S., … Park, W. G. (2015). Cyst Fluid Glucose is Rapidly Feasible and Accurate in Diagnosing Mucinous Pancreatic Cysts. American Journal of Gastroenterology, 110(6), 909–14.
- Leiomyosarcoma: One Disease or Distinct Biologic Entities Based on Site of Origin?
  Worhunsky, D. J., Gupta, M., Gholami, S., Tran, T. B., Ganjoo, K. N., van de Rijn, M., … Poultsides, G. A. (2015). Leiomyosarcoma: One Disease or Distinct Biologic Entities Based on Site of Origin? JOURNAL OF SURGICAL ONCOLOGY, 111(7), 808–12.
- Severe acute pancreatitis in the community: confusion reigns
  Dua, M. M., Worhunsky, D. J., Tran, T. B., Rumma, R. T., Poultsides, G. A., Norton, J. A., … Visser, B. C. (2015). Severe acute pancreatitis in the community: confusion reigns. JOURNAL OF SURGICAL RESEARCH, 199(1), 44–50.
- Prognostic relevance of lymph node ratio and total lymph node count for small bowel adenocarcinoma
  Tran, T. B., Qadan, M., Dua, M. M., Norton, J. A., Poultsides, G. A., & Visser, B. C. (2015). Prognostic relevance of lymph node ratio and total lymph node count for small bowel adenocarcinoma. SURGERY, 158(2), 486–93.
- Hepato-pancreatectomy: how morbid? Results from the national surgical quality improvement project.
  Tran, T. B., Dua, M. M., Spain, D. A., Visser, B. C., Norton, J. A., & Poultsides, G. A. (2015). Hepato-pancreatectomy: how morbid? Results from the national surgical quality improvement project. HPB , 17(9), 763–69.
- Predictive Factors for Surgery Among Patients with Pancreatic Cysts in the Absence of High-Risk Features for Malignancy
  Quan, S. Y., Visser, B. C., Poultsides, G. A., Norton, J. A., Chen, A. M., Banerjee, S., … Park, W. G. (2015). Predictive Factors for Surgery Among Patients with Pancreatic Cysts in the Absence of High-Risk Features for Malignancy. JOURNAL OF GASTROINTESTINAL SURGERY, 19(6), 1101–5.
- Pancreatectomy with vein reconstruction: technique matters
  Dua, M. M., Tran, T. B., Klausner, J., Hwa, K. J., Poultsides, G. A., Norton, J. A., & Visser, B. C. (2015). Pancreatectomy with vein reconstruction: technique matters. HPB, 17(9), 824–31.
- Hepato-pancreatectomy: how morbid? Results from the national surgical quality improvement project
  Tran, T. B., Dua, M. M., Spain, D. A., Visser, B. C., Norton, J. A., & Poultsides, G. A. (2015). Hepato-pancreatectomy: how morbid? Results from the national surgical quality improvement project. HPB, 17(9), 763–69.
- Primary Gastric Hodgkin's Lymphoma: An Extremely Rare Entity and A Diagnostic Challenge.
  Sethi, S., Higgins, J. P., Arber, D. A., Visser, B., & Banerjee, S. (2015). Primary Gastric Hodgkin's Lymphoma: An Extremely Rare Entity and A Diagnostic Challenge. Digestive Diseases and Sciences, 60(10), 2923–26.
- Laparoscopic transgastric necrosectomy for the management of pancreatic necrosis.
  Worhunsky, D. J., Qadan, M., Dua, M. M., Park, W. G., Poultsides, G. A., Norton, J. A., & Visser, B. C. (2014). Laparoscopic transgastric necrosectomy for the management of pancreatic necrosis. Journal of the American College of Surgeons, 219(4), 735–43.
- Single- versus multifraction stereotactic body radiation therapy for pancreatic adenocarcinoma: outcomes and toxicity.
  Pollom, E. L., Alagappan, M., von Eyben, R., Kunz, P. L., Fisher, G. A., Ford, J. A., … Chang, D. T. (2014). Single- versus multifraction stereotactic body radiation therapy for pancreatic adenocarcinoma: outcomes and toxicity. International Journal of Radiation Oncology, Biology, Physics, 90(4), 918–25.
- Pancreatectomy with vein reconstruction: technique matters.
  Dua, M. M., Tran, T. B., Klausner, J., Hwa, K. J., Poultsides, G. A., Norton, J. A., & Visser, B. C. (2015). Pancreatectomy with vein reconstruction: technique matters. HPB , 17(9), 824–31.
- Sarcoma Resection With and Without Vascular Reconstruction: A Matched Case-control Study
  Poultsides, G. A., Tran, T. B., Zambrano, E., Janson, L., Mohler, D. G., Mell, M. W., … Norton, J. A. (2015). Sarcoma Resection With and Without Vascular Reconstruction: A Matched Case-control Study. ANNALS OF SURGERY, 262(4), 632–40.
- Stereotactic body radiation therapy and central liver toxicity: A case report.
  Shaffer, J. L., Osmundson, E. C., Visser, B. C., Longacre, T. A., Koong, A. C., & Chang, D. T. (2015). Stereotactic body radiation therapy and central liver toxicity: A case report. Practical Radiation Oncology, 5(5), 282–85.
- Missing the obvious: psychosocial obstacles in Veterans with hepatocellular carcinoma
  Hwa, K. J., Dua, M. M., Wren, S. M., & Visser, B. C. (2015). Missing the obvious: psychosocial obstacles in Veterans with hepatocellular carcinoma. HPB, 17(12), 1124–29.
- The neurosurgical origins of image-guided surgery
  Barrese, J. C., & Henderson, J. M. (2015). The neurosurgical origins of image-guided surgery. CURRENT PROBLEMS IN SURGERY, 52(12), 476–520.
- Statin and Metformin Use Prolongs Survival in Patients With Resectable Pancreatic Cancer.
  Kozak, M. M., Anderson, E. M., von Eyben, R., Pai, J. S., Poultsides, G. A., Visser, B. C., … Chang, D. T. (2016). Statin and Metformin Use Prolongs Survival in Patients With Resectable Pancreatic Cancer. Pancreas, 45(1), 64–70.
- Management of Postoperative Hepatic Failure
  Qadan, M., Garden, O. J., Corvera, C. U., & Visser, B. C. (2016). Management of Postoperative Hepatic Failure. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 222(2), 195–208.
- Identification of tumorigenic cells and therapeutic targets in pancreatic neuroendocrine tumors
  Krampitz, G. W., George, B. M., Willingham, S. B., Volkmer, J.-P., Weiskopf, K., Jahchan, N., … Weissman, I. L. (2016). Identification of tumorigenic cells and therapeutic targets in pancreatic neuroendocrine tumors. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 113(16), 4464–69.
- Image-guided surgery.
  Azagury, D. E., Dua, M. M., Barrese, J. C., Henderson, J. M., Buchs, N. C., Ris, F., … Visser, B. C. (2015). Image-guided surgery. Current Problems in Surgery, 52(12), 476–520.
- Neuroendocrine tumors of the pancreas: Degree of cystic component predicts prognosis.
  Cloyd, J. M., Kopecky, K. E., Norton, J. A., Kunz, P. L., Fisher, G. A., Visser, B. C., … Poultsides, G. A. (2016). Neuroendocrine tumors of the pancreas: Degree of cystic component predicts prognosis. Surgery, 160(3), 708–13.
- An economic analysis of pancreaticoduodenectomy: should costs drive consumer decisions?
  Tran, T. B., Dua, M. M., Worhunsky, D. J., Poultsides, G. A., Norton, J. A., & Visser, B. C. (2016). An economic analysis of pancreaticoduodenectomy: should costs drive consumer decisions? AMERICAN JOURNAL OF SURGERY, 211(6), 991-?
- The First Decade of Laparoscopic Pancreaticoduodenectomy in the United States: Costs and Outcomes Using the Nationwide Inpatient Sample
  Tran, T. B., Dua, M. M., Worhunsky, D. J., Poultsides, G. A., Norton, J. A., & Visser, B. C. (2016). The First Decade of Laparoscopic Pancreaticoduodenectomy in the United States: Costs and Outcomes Using the Nationwide Inpatient Sample. SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 30(5), 1778–83.
- Biliary Cystadenoma: A Suggested "Cystamatic" Approach?
  Dua, M. M., Gerry, J., Salles, A., Tran, T. B., Triadafilopoulos, G., & Visser, B. C. (2016). Biliary Cystadenoma: A Suggested "Cystamatic" Approach? DIGESTIVE DISEASES AND SCIENCES, 61(7), 1835–38.
- The significance of underlying cardiac comorbidity on major adverse cardiac events after major liver resection.
  Tran, T. B., Worhunsky, D. J., Spain, D. A., Dua, M. M., Visser, B. C., Norton, J. A., & Poultsides, G. A. (2016). The significance of underlying cardiac comorbidity on major adverse cardiac events after major liver resection. HPB , 18(9), 742–47.
- Laparoscopic hepatectomy in cirrhotics: safe if you adjust technique.
  Worhunsky, D. J., Dua, M. M., Tran, T. B., Siu, B., Poultsides, G. A., Norton, J. A., & Visser, B. C. (2016). Laparoscopic hepatectomy in cirrhotics: safe if you adjust technique. Surgical Endoscopy, 30(10), 4307–14.
- Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA
  Scherer, F., Kurtz, D. M., Newman, A. M., Stehr, H., Craig, A. F. M., Esfahani, M. S., … Alizadeh, A. A. (2016). Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA. SCIENCE TRANSLATIONAL MEDICINE, 8(364).
- Enumeration and targeted analysis of KRAS, BRAF and PIK3CA mutations in CTCs captured by a label-free platform: Comparison to ctDNA and tissue in metastatic colorectal cancer
  Kidess-Sigal, E., Liu, H. E., Triboulet, M. M., Che, J., Ramani, V. C., Visser, B. C., … Jeffrey, S. S. (2016). Enumeration and targeted analysis of KRAS, BRAF and PIK3CA mutations in CTCs captured by a label-free platform: Comparison to ctDNA and tissue in metastatic colorectal cancer. ONCOTARGET, 7(51), 85349–64.
- Recurrent Pyogenic Cholangitis: Got Stones?
  Gholami, S., Wood, L., Berry, G., Triadafilopoulos, G., Visser, B. C., & Dua, M. M. (2016). Recurrent Pyogenic Cholangitis: Got Stones? Digestive Diseases and Sciences, 61(11), 3147–50.
- Green Sludge: Intraductal Papillary Mucinous Neoplasm of the Bile Duct Presenting with Intermittent Biliary Obstruction Due to Abundant Mucus.
  Choudhary, A., Barakat, M. T., Leal, J. N., Louie, C. Y., Visser, B. C., & Banerjee, S. (2016). Green Sludge: Intraductal Papillary Mucinous Neoplasm of the Bile Duct Presenting with Intermittent Biliary Obstruction Due to Abundant Mucus. Digestive Diseases and Sciences, -?
- Validation of Fistula Risk Score calculator in diverse North American HPB practices.
  Grendar, J., Jutric, Z., Leal, J. N., Ball, C. G., Bertens, K., Dixon, E., … Hansen, P. D. (2017). Validation of Fistula Risk Score calculator in diverse North American HPB practices. HPB .
- Fukuoka and AGA Criteria Have Superior Diagnostic Accuracy for Advanced Cystic Neoplasms than Sendai Criteria.
  Sighinolfi, M., Quan, S. Y., Lee, Y., Ibaseta, A., Pham, K., Dua, M. M., … Park, W. G. (2017). Fukuoka and AGA Criteria Have Superior Diagnostic Accuracy for Advanced Cystic Neoplasms than Sendai Criteria. Digestive Diseases and Sciences, 62(3), 626–32.
- Duodenal adenocarcinoma: Advances in diagnosis and surgical management.
  Cloyd, J. M., George, E., & Visser, B. C. (2016). Duodenal adenocarcinoma: Advances in diagnosis and surgical management. World Journal of Gastrointestinal Surgery, 8(3), 212–21.
- Surgical Approaches to Chronic Pancreatitis: Indications and Techniques.
  Dua, M. M., & Visser, B. C. (2017). Surgical Approaches to Chronic Pancreatitis: Indications and Techniques. Digestive Diseases and Sciences.
- Development and Validation of Biopsy-Free Genotyping for Molecular Subtyping of Diffuse Large B-Cell Lymphoma
  Scherer, F., Kurtz, D. M., Newman, A. M., Esfahani, M. S., Craig, A., Stehr, H., … Alizadeh, A. A. (2016). Development and Validation of Biopsy-Free Genotyping for Molecular Subtyping of Diffuse Large B-Cell Lymphoma. BLOOD. SAN DIEGO,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA: AMER SOC HEMATOLOGY.
- Improving Care With a Portfolio of Physician-Led Cancer Quality Measures at an Academic Center
  Porter, J. B. (2017). Improving Care With a Portfolio of Physician-Led Cancer Quality Measures at an Academic Center. Improving Care With a Portfolio of Physician-Led Cancer Quality Measures at an Academic Center, 13(8), e673–e682.
- When Lightning Strikes Twice.
  Baiu, I., Charville, G. W., & Visser, B. C. (2018). When Lightning Strikes Twice. Digestive Diseases and Sciences.
- Prospective Evaluation of Results of Reoperation in Zollinger-Ellison Syndrome.
  Norton, J. A., Krampitz, G. W., Poultsides, G. A., Visser, B. C., Fraker, D. L., Alexander, H. R., & Jensen, R. T. (2018). Prospective Evaluation of Results of Reoperation in Zollinger-Ellison Syndrome. Annals of Surgery, 267(4), 782–88.
- Incidence and Prognosis of Primary Gastrinomas in the Hepatobiliary Tract
  Norton, J. A., Foster, D. S., Blumgart, L. H., Poultsides, G. A., Visser, B. C., Fraker, D. L., … Jensen, R. T. (2018). Incidence and Prognosis of Primary Gastrinomas in the Hepatobiliary Tract. JAMA SURGERY, 153(3), e175083.
- Management of Borderline Resectable Pancreatic Cancer.
  Toesca, D. A., Koong, A. J., Poultsides, G. A., Visser, B. C., Haraldsdottir, S., Koong, A. C., & Chang, D. T. (2018). Management of Borderline Resectable Pancreatic Cancer. International Journal of Radiation Oncology, Biology, Physics, 100(5), 1155–74.
- Prediction of pancreatic cancer surgical outcomes and prognosis based on an objective resectability scoring system
  Toesca, D. A. S., Jeffrey, B., von Eyben, R., Poullos, P. D., Poultsides, G. A., Fisher, G. A., … Chang, D. T. (2018). Prediction of pancreatic cancer surgical outcomes and prognosis based on an objective resectability scoring system. Journal of Clinical Oncology. San Francisco, CA.
- The Effect of Chronic Kidney Disease on Postoperative Outcomes after Major Hepatectomy: Results from the National Surgical Quality Improvement Program
  Tran, T. B., Dua, M. M., Spain, D. A., Poultsides, G. A., Norton, J. A., & Visser, B. C. (2015). The Effect of Chronic Kidney Disease on Postoperative Outcomes after Major Hepatectomy: Results from the National Surgical Quality Improvement Program. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 221(4), S94–S95.
- Noninvasive Genotyping and Assessment of Treatment Response in Diffuse Large B Cell Lymphoma
  Scherer, F., Kurtz, D. M., Newman, A. M., Stehr, H., Liu, C. L., Zhou, L., … Alizadeh, A. A. (2015). Noninvasive Genotyping and Assessment of Treatment Response in Diffuse Large B Cell Lymphoma. BLOOD. AMER SOC HEMATOLOGY.
- Pretreatment lab values to predict overall survival in patients with primary unresectable pancreatic adenocarcinoma treated with SBRT
  Alagappan, M., Pollom, E. L., von Eyben, R., Kunz, P. L., Fisher, G. A., Ford, J. M., … Chang, D. T. (2015). Pretreatment lab values to predict overall survival in patients with primary unresectable pancreatic adenocarcinoma treated with SBRT. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY.
- Transgastric pancreatic necrosectomy-expedited return to prepancreatitis health
  Dua, M. M., Worhunsky, D. J., Malhotra, L., Park, W. G., Poultsides, G. A., Norton, J. A., & Visser, B. C. (2017). Transgastric pancreatic necrosectomy-expedited return to prepancreatitis health. JOURNAL OF SURGICAL RESEARCH, 219, 11–17.
- Minimally invasive approaches to resection of benign/low-grade gastric tumors
  Salles, A., Dua, M., Friedland, S., & Visser, B. (2016). Minimally invasive approaches to resection of benign/low-grade gastric tumors. SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 30(6), 2624–25.
- Hepato-pancreatectomy: perioperative and long term outcomes of synchronous hepatic and pancreatic resection
  Tran, T. B., Dua, M. M., Visser, B. C., Norton, J. A., & Poultsides, G. A. (2015). Hepato-pancreatectomy: perioperative and long term outcomes of synchronous hepatic and pancreatic resection. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 221(4), E95.
- Management of Postoperative Pancreatic Fistula: Drain Position Matters
  Malhotra, L., Dua, M. M., Leal, J. N., Poultsides, G. A., Norton, J. A., & Visser, B. C. (2017). Management of Postoperative Pancreatic Fistula: Drain Position Matters. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 225(4), E123–E124.
- Surgical Strategies for the Management of Necrotizing Pancreatitis
  Dua, M. M., Worhunsky, D. J., Tran, T. B., Friedland, S., Park, W. G., & Visser, B. C. (2015). Surgical Strategies for the Management of Necrotizing Pancreatitis. JOURNAL OF THE PANCREAS, 16(6), 547–58.
- Monitoring Gastric Myoelectric Activity After Pancreaticoduodenectomy for Diet "Readiness".
  Dua, M. M., Navalgund, A., Axelrod, S., Axelrod, L., Worth, P. J., Norton, J. A., … Visser, B. C. (2018). Monitoring Gastric Myoelectric Activity After Pancreaticoduodenectomy for Diet "Readiness". American Journal of Physiology. Gastrointestinal and Liver Physiology.
- Surgical and molecular characterization of primary and metastatic disease in a neuroendocrine tumor arising in a tailgut cyst.
  Erdrich, J., Schaberg, K., Khodadoust, M. S., Zhou, L., Shelton, A. A., Visser, B. C., … Beausang, J. F. (2018). Surgical and molecular characterization of primary and metastatic disease in a neuroendocrine tumor arising in a tailgut cyst. Cold Spring Harbor Molecular Case Studies.
- Noninvasive Detection of BCL2, BCL6, and MYC Translocations in Diffuse Large B-Cell Lymphoma
  Kurtz, D. M., Scherer, F., Newman, A. M., Craig, A., Jin, M., Stehr, H., … Alizadeh, A. A. (2016). Noninvasive Detection of BCL2, BCL6, and MYC Translocations in Diffuse Large B-Cell Lymphoma. BLOOD. AMER SOC HEMATOLOGY.
- Isolated pancreatic tail remnants after transgastric necrosectomy can be observed.
  Dua, M. M., Jensen, C. W., Friedland, S., Worth, P. J., Poultsides, G. A., Norton, J. A., … Visser, B. C. (2018). Isolated pancreatic tail remnants after transgastric necrosectomy can be observed. The Journal of Surgical Research, 231, 109–15.
- Circulating tumor DNA (ctDNA) in B-cell lymphoma
  Scherer, F., Kurtz, D. M., Newman, A. M., Stehr, H., Craig, A. F. M., Esfahani, M. S., … Alizadeh, A. A. (2018). Circulating tumor DNA (ctDNA) in B-cell lymphoma. BRITISH JOURNAL OF HAEMATOLOGY. WILEY.
- Ruptured Oncocytic Intraductal Papillary Neoplasm: Think Beyond the Pancreas.
  Jensen, C. W., Worhunsky, D. J., Triadafilopoulos, G., Bingham, D. B., & Visser, B. C. (2019). Ruptured Oncocytic Intraductal Papillary Neoplasm: Think Beyond the Pancreas. Digestive Diseases and Sciences.
- Minimally Invasive Small Bowel Cancer Surgery.
  Baiu, I., & Visser, B. C. (2019). Minimally Invasive Small Bowel Cancer Surgery. Surgical Oncology Clinics of North America, 28(2), 273–83.
- Identification of Tumorigenic Cells and Therapeutic Targets in Pancreatic Neuroendocrine Cancers
  Krampitz, G. W., Willingham, S. B., Volkmer, J. P., Weiskopf, K. A., George, B. M., Sage, J., … Weissman, I. L. (2015). Identification of Tumorigenic Cells and Therapeutic Targets in Pancreatic Neuroendocrine Cancers. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 221(4), S59–S60.
- Performance of a novel TNM staging system for pancreatic neuroendocrine tumors versus the current AJCC staging system
  Qadan, M., Ma, Y., Visser, B. C., Norton, J. A., & Poultsides, G. A. (2013). Performance of a novel TNM staging system for pancreatic neuroendocrine tumors versus the current AJCC staging system. JOURNAL OF CLINICAL ONCOLOGY, 31(4).
- Shades of 'Childs A': successful laparoscopic major hepatectomies in cirrhotics
  Worth, P. J., & Visser, B. C. (2017). Shades of 'Childs A': successful laparoscopic major hepatectomies in cirrhotics. ANNALS OF LAPAROSCOPIC AND ENDOSCOPIC SURGERY, 2.
- Surgical Transgastric Necrosectomy for Necrotizing Pancreatitis: A Single-stage Procedure for Walled-off Pancreatic Necrosis.
  Driedger, M., Zyromski, N. J., Visser, B. C., Jester, A., Sutherland, F. R., Nakeeb, A., … Ball, C. G. (2018). Surgical Transgastric Necrosectomy for Necrotizing Pancreatitis: A Single-stage Procedure for Walled-off Pancreatic Necrosis. Annals of Surgery.
- Colorectal liver metastases management in the Veterans Health Administration: Geographic disparity.
  Mobarek, D. A., Visser, B. C., Krasnow, S., Chang, J. W., Nechodom, P., & DuVall, S. L. (2016). Colorectal liver metastases management in the Veterans Health Administration: Geographic disparity. JOURNAL OF CLINICAL ONCOLOGY, 34(4).
- Management of colorectal hepatic met stases in the Veterans Affairs medical system: Opportunities for curative intent surgery
  Mobarek, D. A., Visser, B. C., Freeman, A., Bentt, D., Ayvazian, J., Maron, D., … Krasnow, S. (2014). Management of colorectal hepatic met stases in the Veterans Affairs medical system: Opportunities for curative intent surgery. JOURNAL OF CLINICAL ONCOLOGY, 32(15).
- Nullius in Verba INVITED CRITIQUE
  Visser, B. C. (2013). Nullius in Verba INVITED CRITIQUE. JAMA SURGERY, 148(3), 257–58.
- Sarcoma Resection With and Without Vascular Reconstruction: A Matched Case-control Study.
  Poultsides, G. A., Tran, T. B., Zambrano, E., Janson, L., Mohler, D. G., Mell, M. W., … Norton, J. A. (2015). Sarcoma Resection With and Without Vascular Reconstruction: A Matched Case-control Study. Annals of Surgery, 262(4), 632–40.
- Prognostic relevance of lymph node ratio and total lymph node count for small bowel adenocarcinoma.
  Tran, T. B., Qadan, M., Dua, M. M., Norton, J. A., Poultsides, G. A., & Visser, B. C. (2015). Prognostic relevance of lymph node ratio and total lymph node count for small bowel adenocarcinoma. Surgery, 158(2), 486–93.
- Missing the obvious: psychosocial obstacles in Veterans with hepatocellular carcinoma.
  Hwa, K. J., Dua, M. M., Wren, S. M., & Visser, B. C. (2015). Missing the obvious: psychosocial obstacles in Veterans with hepatocellular carcinoma. HPB : the Official Journal of the International Hepato Pancreato Biliary Association.
- Management of Postoperative Hepatic Failure.
  Qadan, M., Garden, O. J., Corvera, C. U., & Visser, B. C. (2016). Management of Postoperative Hepatic Failure. Journal of the American College of Surgeons, 222(2), 195–208.
- Improving care with portfolio of physician-led cancer quality measures at an academic center
  Porter, J., Smith, A. S., Winget, M., Rosenthal, E. L., Seshadri, S. B., Vetteth, Y., … Blayney, D. W. (2017). Improving care with portfolio of physician-led cancer quality measures at an academic center. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY.
- Prospective Evaluation of Results of Reoperation in Zollinger-Ellison Syndrome
  Norton, J. A., Krampitz, G. W., Poultsides, G. A., Visser, B. C., Fraker, D. L., Alexander, H. R., & Jensen, R. T. (2018). Prospective Evaluation of Results of Reoperation in Zollinger-Ellison Syndrome. ANNALS OF SURGERY, 267(4), 782–88.
- Surgical and molecular characterization of primary and metastatic disease in a neuroendocrine tumor arising in a tailgut cyst
  Erdrich, J., Schaberg, K. B., Khodadoust, M. S., Zhou, L., Shelton, A. A., Visser, B. C., … Beausang, J. F. (2018). Surgical and molecular characterization of primary and metastatic disease in a neuroendocrine tumor arising in a tailgut cyst. COLD SPRING HARBOR MOLECULAR CASE STUDIES, 4(5).
- Isolated pancreatic tail remnants after transgastric necrosectomy can be observed
  Dua, M. M., Jensen, C. W., Friedland, S., Worth, P. J., Poultsides, G. A., Norton, J. A., … Visser, B. C. (2018). Isolated pancreatic tail remnants after transgastric necrosectomy can be observed. JOURNAL OF SURGICAL RESEARCH, 231, 109–15.
- Monitoring gastric myoelectric activity after pancreaticoduodenectomy for diet "readiness"
  Dua, M. M., Navalgund, A., Axelrod, S., Axelrod, L., Worth, P. J., Norton, J. A., … Visser, B. C. (2018). Monitoring gastric myoelectric activity after pancreaticoduodenectomy for diet "readiness". AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 315(5), G743–G751.
- When Lightning Strikes Twice
  Baiu, I., Charville, G. W., & Visser, B. C. (2018). When Lightning Strikes Twice. DIGESTIVE DISEASES AND SCIENCES, 63(10), 2536–40.
- Predicting Pancreatic Cancer Resectability and Outcomes Based on an Objective Quantitative Scoring System.
  Toesca, D. A., Jeffrey, R. B., von Eyben, R., Pollom, E. L., Poullos, P. D., Poultsides, G. A., … Chang, D. T. Predicting Pancreatic Cancer Resectability and Outcomes Based on an Objective Quantitative Scoring System. Pancreas, 48(5), 622–28.
- Ruptured Oncocytic Intraductal Papillary Neoplasm: Think Beyond the Pancreas
  Jensen, C. W., Worhunsky, D. J., Triadafilopoulos, G., Bingham, D. B., & Visser, B. C. (2019). Ruptured Oncocytic Intraductal Papillary Neoplasm: Think Beyond the Pancreas. DIGESTIVE DISEASES AND SCIENCES, 64(6), 1436–38.
- Management of Ileal Neuroendocrine Tumors with Liver Metastases.
  Fisher, A. T., Titan, A. L., Foster, D. S., Worth, P. J., Poultsides, G. A., Visser, B. C., … Norton, J. A. (2019). Management of Ileal Neuroendocrine Tumors with Liver Metastases. Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract.
- Predicting Pancreatic Cancer Resectability and Outcomes Based on an Objective Quantitative Scoring System
  Toesca, D. A. S., Jeffrey, R. B., von Eyben, R., Pollom, E. L., Poullos, P. D., Poultsides, G. A., … Chang, D. T. (2019). Predicting Pancreatic Cancer Resectability and Outcomes Based on an Objective Quantitative Scoring System. PANCREAS. LIPPINCOTT WILLIAMS & WILKINS.
- Minimally Invasive Small Bowel Cancer Surgery
  Baiu, I., & Visser, B. C. (2019). Minimally Invasive Small Bowel Cancer Surgery. SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 28(2), 273-+.
- Evaluation of integrin alphavbeta6 cystine knot PET tracers to detect cancer and idiopathic pulmonary fibrosis.
  Kimura, R. H., Wang, L., Shen, B., Huo, L., Tummers, W., Filipp, F. V., … Gambhir, S. S. (2019). Evaluation of integrin alphavbeta6 cystine knot PET tracers to detect cancer and idiopathic pulmonary fibrosis. Nature Communications, 10(1), 4673.
- Postoperative Outcomes of Laparoscopic vs Robotic Distal Pancreatectomy: A Propensity-Matched Analysis
  Jensen, C. W., Baiocchi, M., Dua, M. M., Poultsides, G. A., Norton, J. A., Worth, P. J., & Visser, B. C. (2019). Postoperative Outcomes of Laparoscopic vs Robotic Distal Pancreatectomy: A Propensity-Matched Analysis. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 229(4), S181–S182.
- Pancreatic grade 3 neuroendocrine tumors behave similarly to neuroendocrine carcinomas following resection: a multi-center, international appraisal of the WHO 2010 and WHO 2017 staging schema for pancreatic neuroendocrine lesions.
  Worth, P. J., Leal, J., Ding, Q., Trickey, A., Dua, M. M., Chatzizacharias, N., … Visser, B. C. (2020). Pancreatic grade 3 neuroendocrine tumors behave similarly to neuroendocrine carcinomas following resection: a multi-center, international appraisal of the WHO 2010 and WHO 2017 staging schema for pancreatic neuroendocrine lesions. HPB : the Official Journal of the International Hepato Pancreato Biliary Association.
- Neoadjuvant Capecitabine/Temozolomide for Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors.
  Squires, M. H., Worth, P. J., Konda, B., Shah, M. H., Dillhoff, M. E., Abdel-Misih, S., … Cloyd, J. M. (2020). Neoadjuvant Capecitabine/Temozolomide for Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors. Pancreas.
- Questionable Survival Benefit of Aspirin Use in Patients With Biliary Tract Cancer.
  Bergquist, J. R., Shariq, O. A., & Visser, B. C. (2020). Questionable Survival Benefit of Aspirin Use in Patients With Biliary Tract Cancer. JAMA Oncology.
- Minimally invasive options for gastrointestinal stromal tumors of the stomach.
  Mazer, L., Worth, P., & Visser, B. (2020). Minimally invasive options for gastrointestinal stromal tumors of the stomach. Surgical Endoscopy.
- Nearing the Summit: Associating Liver Partitioning and Portal Ligation for Staged Hepatectomy (ALPPS) in Progressive Carcinoid Disease.
  Bergquist, J. R., Li, A. Y., Chang, E. M., Scott, G. D., Dua, M. M., & Visser, B. C. (2020). Nearing the Summit: Associating Liver Partitioning and Portal Ligation for Staged Hepatectomy (ALPPS) in Progressive Carcinoid Disease. Digestive Diseases and Sciences.
- Surgical Transgastric Necrosectomy for Necrotizing Pancreatitis A Single-stage Procedure for Walled-off Pancreatic Necrosis
  Driedger, M., Zyromski, N. J., Visser, B. C., Jester, A., Sutherland, F. R., Nakeeb, A., … Ball, C. G. (2020). Surgical Transgastric Necrosectomy for Necrotizing Pancreatitis A Single-stage Procedure for Walled-off Pancreatic Necrosis. ANNALS OF SURGERY, 271(1), 163–68.
- Role of yttrium-90 selective internal radiation therapy in the treatment of liver-dominant metastatic colorectal cancer: an evidence-based expert consensus algorithm
  Jeyarajah, D. R., Doyle, M. B. M., Espat, N. J., Hansen, P. D., Iannitti, D. A., Kim, J., … Visser, B. C. (2020). Role of yttrium-90 selective internal radiation therapy in the treatment of liver-dominant metastatic colorectal cancer: an evidence-based expert consensus algorithm. JOURNAL OF GASTROINTESTINAL ONCOLOGY, 11(2), 443–60.
- Laparoscopic hepatic lobectomy for symptomatic polycystic liver disease.
  Li, A. Y., Bergquist, J. R., August, A. T., Dua, M. M., Poultsides, G. A., & Visser, B. C. (2020). Laparoscopic hepatic lobectomy for symptomatic polycystic liver disease. HPB : the Official Journal of the International Hepato Pancreato Biliary Association.
- Evaluation of Outcomes Following Surgery for Locally Advanced Pancreatic Neuroendocrine Tumors.
  Titan, A. L., Norton, J. A., Fisher, A. T., Foster, D. S., Harris, E. J., Worhunsky, D. J., … Jensen, R. T. (2020). Evaluation of Outcomes Following Surgery for Locally Advanced Pancreatic Neuroendocrine Tumors. JAMA Network Open, 3(11), e2024318.
- Too Big to Fail: Successful Resection of a Large Hepatocellular Carcinoma with Portal Tumor Thrombus.
  Bergquist, J. R., Li, A. Y., Javadi, C. S., Chima, R. S., Frye, J. S., & Visser, B. C. (2020). Too Big to Fail: Successful Resection of a Large Hepatocellular Carcinoma with Portal Tumor Thrombus. Digestive Diseases and Sciences.
- Segmental resection of the fourth duodenal portion using the Da Vinci Robot
  Allue Cabanuz, M., & Visser, B. C. (2020). Segmental resection of the fourth duodenal portion using the Da Vinci Robot. CIRUGIA ESPANOLA, 98(10), 625.
- Regional lymph node sampling in hepatoma resection: insight into prognosis.
  Bergquist, J. R., Li, A. Y., Javadi, C. S., Lee, B., Norton, J. A., Poultsides, G. A., … Visser, B. C. (2021). Regional lymph node sampling in hepatoma resection: insight into prognosis. HPB : the Official Journal of the International Hepato Pancreato Biliary Association.
- Mastering the thousand tiny details: Routine use of video to optimize performance in sport and in surgery.
  Jopling, J. K., & Visser, B. C. (2021). Mastering the thousand tiny details: Routine use of video to optimize performance in sport and in surgery. ANZ Journal of Surgery.
- Necrosectomy in the Management of Necrotizing Pancreatitis.
  Li, A. Y., Bergquist, J. R., & Visser, B. C. (2021). Necrosectomy in the Management of Necrotizing Pancreatitis. Advances in Surgery, 55, 231–250.
- Same soup different taste-how to best manage the future liver remnant-a surgical perspective
  Bergquist, J. R., Starlinger, P., & Visser, B. C. (2021). Same soup different taste-how to best manage the future liver remnant-a surgical perspective. HEPATOBILIARY SURGERY AND NUTRITION.
- More Than an ERAS Pathway is Needed to Meet Target Length of Stay After Pancreaticoduodenectomy.
  Ayala, C. I., Li, A. Y., Lu, A., Wilson, A., Bergquist, J. R., Poultsides, G. A., … Dua, M. M. (2021). More Than an ERAS Pathway is Needed to Meet Target Length of Stay After Pancreaticoduodenectomy. The Journal of Surgical Research, 270, 195–202.
- Surgical resection of leiomyosarcoma of the inferior vena cava: A case series and literature review.
  Zhou, M., Javadi, C., Charville, G. W., Bui, N. Q., Harris, E. J., Poultsides, G. A., … Ganjoo, K. N. (2021). Surgical resection of leiomyosarcoma of the inferior vena cava: A case series and literature review. Surgical Oncology, 39, 101670.
- Same soup different taste-how to best manage the future liver remnant-a surgical perspective.
  Bergquist, J. R., Starlinger, P., & Visser, B. C. (2021). Same soup different taste-how to best manage the future liver remnant-a surgical perspective. Hepatobiliary Surgery and Nutrition, 10(5), 734–736.
- Radiographic, Biochemical, or Pathologic Response to Neoadjuvant Chemotherapy in Resected Pancreatic Cancer: Which Is Best?
  Javadi, C., Chang, J., Forgo, E., Ahmad, M. U., Fisher, G. A., Chang, D. T., … Poultsides, G. A. (2022). Radiographic, Biochemical, or Pathologic Response to Neoadjuvant Chemotherapy in Resected Pancreatic Cancer: Which Is Best? ANNALS OF SURGICAL ONCOLOGY. SPRINGER.
- Robotic Living Donor Right Hepatectomy: A Systematic Review and Meta-Analysis.
  Lincango Naranjo, E. P., Garces-Delgado, E., Siepmann, T., Mirow, L., Solis-Pazmino, P., Alexander-Leon, H., … Moris, D. (2022). Robotic Living Donor Right Hepatectomy: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine, 11(9).
- Surgical Indications and Outcomes of Resection for Pancreatic Neuroendocrine Tumors with Vascular Involvement.
  Li, A. Y., Visser, B. C., & Dua, M. M. (2022). Surgical Indications and Outcomes of Resection for Pancreatic Neuroendocrine Tumors with Vascular Involvement. Cancers, 14(9).
- Clinical features and postoperative survival in patients with sporadic versus multiple endocrine neoplasia type 1-related pancreatic neuroendocrine tumors: An international cohort study.
  Bergquist, J. R., Shariq, O. A., Li, A. Y., Worth, P. J., Chatzizacharias, N., Soonawalla, Z., … Visser, B. C. (2022). Clinical features and postoperative survival in patients with sporadic versus multiple endocrine neoplasia type 1-related pancreatic neuroendocrine tumors: An international cohort study. Surgery.
- Establishment and Application of a Novel Difficulty Scoring System for da Vinci Robotic Pancreatoduodenectomy.
  Sun, H., Sun, C., Zhang, B., Ma, K., Wu, Z., Visser, B. C., & Han, B. (2022). Establishment and Application of a Novel Difficulty Scoring System for da Vinci Robotic Pancreatoduodenectomy. Frontiers in Surgery, 9, 916014.
- Conclusions and recommendations of an AHPBA-commissioned assessment of strengths, weaknesses, opportunities, and threats facing fellowship training in HPB surgery.
  Warner, S. G., Babicky, M., Alseidi, A., & Visser, B. (2022). Conclusions and recommendations of an AHPBA-commissioned assessment of strengths, weaknesses, opportunities, and threats facing fellowship training in HPB surgery. HPB : the Official Journal of the International Hepato Pancreato Biliary Association.
- AHPBA senior leaders' assessments of strengths, weaknesses, opportunities, and threats facing fellowship training in HPB surgery: "We need to standardize our training experiences".
  Miller, P., Romero-Hernandez, F., Mora, R. V., Hughes, D., Babicky, M., Warner, S., … Visser, B. (2022). AHPBA senior leaders' assessments of strengths, weaknesses, opportunities, and threats facing fellowship training in HPB surgery: "We need to standardize our training experiences". HPB : the Official Journal of the International Hepato Pancreato Biliary Association.
- Surgery, Liver Directed Therapy and Peptide Receptor Radionuclide Therapy for Pancreatic Neuroendocrine Tumor Liver Metastases.
  Ngongoni, R., & Visser, B. (2022). Surgery, Liver Directed Therapy and Peptide Receptor Radionuclide Therapy for Pancreatic Neuroendocrine Tumor Liver Metastases. Cancers, 14(20).
- Comparison of Spleen-Preservation vs Splenectomy in Minimally Invasive Distal Pancreatectomy: A Propensity-Matched Analysis
  Timmerhuis, H. C., Ngongoni, R. F., Jensen, C., Baiocchi, M., DeLong, J. C., Dua, M. M., … Visser, B. C. (2022). Comparison of Spleen-Preservation vs Splenectomy in Minimally Invasive Distal Pancreatectomy: A Propensity-Matched Analysis. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS. LIPPINCOTT WILLIAMS & WILKINS.
- The job market for HPB surgeons: leadership perspectives on surgeon skillsets, training pathways, and hiring.
  Hughes, D., Romero Hernandez, F., Miller, P., Warner, S., Babicky, M., Visser, B., & Alseidi, A. (2022). The job market for HPB surgeons: leadership perspectives on surgeon skillsets, training pathways, and hiring. HPB : the Official Journal of the International Hepato Pancreato Biliary Association.
- AHPBA graduated fellows' assessments of strengths, weaknesses, opportunities and threats facing fellowship training in HPB surgery: "HPB training excellence means volume, knowledge, and mentorship".
  Romero-Hernandez, F., Miller, P., Mora, R. V., Hughes, D., Warner, S., Alseidi, A., … Babicky, M. (2022). AHPBA graduated fellows' assessments of strengths, weaknesses, opportunities and threats facing fellowship training in HPB surgery: "HPB training excellence means volume, knowledge, and mentorship". HPB : the Official Journal of the International Hepato Pancreato Biliary Association.
- Characterizing gastrointestinal dysfunction after pancreatic resection: a single-center retrospective study.
  Bromley-Dulfano, R., August, A. T., Li, A. Y., Park, W., & Visser, B. (2022). Characterizing gastrointestinal dysfunction after pancreatic resection: a single-center retrospective study. BMC Gastroenterology, 22(1), 488.
- Duodenal perforation due to multiple foreign bodies: consideration for operative approach and surgical repair.
  Wright, K., Rajasingh, C. M., Fu, S. J., Tung, J., Visser, B. C., & Knowlton, L. M. (2022). Duodenal perforation due to multiple foreign bodies: consideration for operative approach and surgical repair. Trauma Surgery & Acute Care Open, 7(1), e001063.
- Validation of a Resectability Scoring System for Prediction of Pancreatic Adenocarcinoma Surgical Outcomes.
  Toesca, D. A., Susko, M., von Eyben, R., Baclay, J. R., Pollom, E. L., Jeffrey, R. B., … Chang, D. T. (2023). Validation of a Resectability Scoring System for Prediction of Pancreatic Adenocarcinoma Surgical Outcomes. Annals of Surgical Oncology.
- Going Virtual: Effect of Implementing Video Visits On Readmission Rates in Gi Surgical Oncology Patients
  DeLong, J. C., Ngongoni, R., Khan, S., Ohkuma, R., Timmerhuis, H. C., Dua, M. M., & Visser, B. C. (2023). Going Virtual: Effect of Implementing Video Visits On Readmission Rates in Gi Surgical Oncology Patients. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS. LIPPINCOTT WILLIAMS & WILKINS.
- Growth Kinetics of Pancreatic Neuroendocrine Neoplasms by Histopathologic Grade.
  Cao, J. J., Shen, L., Visser, B. C., Yoon, L., Kamaya, A., & Tse, J. R. (2023). Growth Kinetics of Pancreatic Neuroendocrine Neoplasms by Histopathologic Grade. Pancreas, 52(2), e135–e143.
- Determinants, Costs, and Consequences of Common Bile Duct Injury Requiring Operative Repair Among Privately Insured Individuals in the United States, 2003-2020.
  Elser, H., Bergquist, J. R., Li, A. Y., & Visser, B. C. (2023). Determinants, Costs, and Consequences of Common Bile Duct Injury Requiring Operative Repair Among Privately Insured Individuals in the United States, 2003-2020. Annals of Surgery Open : Perspectives of Surgical History, Education, and Clinical Approaches, 4(1), e238.
- Comparison of Spleen-Preservation Versus Splenectomy in Minimally Invasive Distal Pancreatectomy.
  Timmerhuis, H. C., Ngongoni, R. F., Jensen, C. W., Baiocchi, M., DeLong, J. C., Dua, M. M., … Visser, B. C. (2023). Comparison of Spleen-Preservation Versus Splenectomy in Minimally Invasive Distal Pancreatectomy. Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract.
- Fragmentation of Gastroesophageal Junction Cancer Care in California Rejoice
  Ngongoni, F., Li, A. Y., Timmerhuis, H., Furst, A., Trickey, A., DeLong, J., … Visser, B. (2023). Fragmentation of Gastroesophageal Junction Cancer Care in California Rejoice. ANNALS OF SURGICAL ONCOLOGY. SPRINGER.
- Single Cell Transcriptomic Analysis of Human Extra- and Intra-Hepatic Cholangiocarcinoma
  Ayala, C. I., Sathe, A., Grimes, S., Bae, X., Dua, M., Poultsides, G., … Ji, H. (2023). Single Cell Transcriptomic Analysis of Human Extra- and Intra-Hepatic Cholangiocarcinoma. ANNALS OF SURGICAL ONCOLOGY. SPRINGER.
- Utilization of parenteral nutrition in major gastrointestinal surgery: An opportunity for quality improvement.
  Aldridge, T. A., Mathias, K. K., Bergquist, J. R., Fong, Y. Y., Li, A. Y., & Visser, B. C. (2023). Utilization of parenteral nutrition in major gastrointestinal surgery: An opportunity for quality improvement. Clinical Nutrition ESPEN, 57, 233–238.
- Multiplatform single cell spatial dissection of the invasive front of hepatocellular carcinoma (HCC) reveals molecular insights into tumor progression
  Zhang, J., Adeniji, N., Suresh, A., Lemaitre, L., Charu, V., Visser, B., … Dhanasekaran, R. (2023). Multiplatform single cell spatial dissection of the invasive front of hepatocellular carcinoma (HCC) reveals molecular insights into tumor progression. JOURNAL OF HEPATOLOGY. ELSEVIER.
- Barriers and Facilitators of Surgical Prehabilitation Adherence from the Patient Perspective: a Mixed Method Study.
  Kimura, C., Liu, Y., Crowder, S. E., Arbaugh, C., Mai, U., Shankar, K., … Kin, C. (2023). Barriers and Facilitators of Surgical Prehabilitation Adherence from the Patient Perspective: a Mixed Method Study. Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract.
- Perceptions of Readiness for Practice After Complex General Surgical Oncology Fellowship: A Survey Study.
  Behrens, S., Lillemoe, H. A., Dineen, S. P., Russell, M. C., Visser, B., Berman, R. S., … Davis, J. L. (2023). Perceptions of Readiness for Practice After Complex General Surgical Oncology Fellowship: A Survey Study. Annals of Surgical Oncology.
- ASO Visual Abstract: Perceptions of Readiness for Practice After Complex General Surgical Oncology Fellowship: A Survey Study.
  Behrens, S., Lillemoe, H. A., Dineen, S. P., Russell, M. C., Visser, B., Berman, R. S., … Davis, J. L. (2023). ASO Visual Abstract: Perceptions of Readiness for Practice After Complex General Surgical Oncology Fellowship: A Survey Study. Annals of Surgical Oncology.
- SINGLE-NUCLEI TARGETED DNA SEQUENCING REVEALS PATTERNS OF SELECTIVE CLONAL EVOLUTION DURING HEPATOCELLULAR CARCINOMA (HCC) PROGRESSION
  Zhang, J., Suresh, A., Lemaitre, L., Agoglia, R., Otero, B., Reguram, R., … Dhanasekaran, R. (2023). SINGLE-NUCLEI TARGETED DNA SEQUENCING REVEALS PATTERNS OF SELECTIVE CLONAL EVOLUTION DURING HEPATOCELLULAR CARCINOMA (HCC) PROGRESSION. HEPATOLOGY. LIPPINCOTT WILLIAMS & WILKINS.
- Postoperative outcomes and costs of laparoscopic versus robotic distal pancreatectomy: a propensity-matched analysis.
  Timmerhuis, H. C., Jensen, C. W., Ngongoni, R. F., Baiocchi, M., DeLong, J. C., Ohkuma, R., … Visser, B. C. (2024). Postoperative outcomes and costs of laparoscopic versus robotic distal pancreatectomy: a propensity-matched analysis. Surgical Endoscopy.
- Overexpression of Senescence-Associated Genes, SFN and CDC6, Correlates with Poor Survival in Patients with Stage II Hepatocellular Carcinoma (HCC)
  Badshah, J., Subramanian, S., Melcher, M., Sasaki, K., Visser, B., Delitto, D., … Kirchner, V. (2024). Overexpression of Senescence-Associated Genes, SFN and CDC6, Correlates with Poor Survival in Patients with Stage II Hepatocellular Carcinoma (HCC). AMERICAN JOURNAL OF TRANSPLANTATION. ELSEVIER SCIENCE INC.
- Distal Pancreatectomy With and Without Celiac Axis Resection for Adenocarcinoma: A Comparison in the Era of Neoadjuvant Therapy
  Daniel, S. K., Hironaka, C., Ahmad, M. U., Delitto, D., Dua, M., Lee, B., … Poultsides, G. (2024). Distal Pancreatectomy With and Without Celiac Axis Resection for Adenocarcinoma: A Comparison in the Era of Neoadjuvant Therapy. ANNALS OF SURGICAL ONCOLOGY. SPRINGER.
- Single cell pharmacogenic pipeline identifies novel opportunities in uterine leiomyosarcoma
  Daniel, S. K., Foster, D., Nosrati, F., Korah, M., Fallah, M., Sun, B. J., … Delitto, D. (2024). Single cell pharmacogenic pipeline identifies novel opportunities in uterine leiomyosarcoma. ANNALS OF SURGICAL ONCOLOGY. SPRINGER.
- A core outcome set for acute necrotizing pancreatitis: An Eastern Association for the Surgery of Trauma modified Delphi method consensus study.
  Farrell, M. S., Alseidi, A., Byerly, S., Fockens, P., Giberson, F. A., Glaser, J., … Gelbard, R. B. (2024). A core outcome set for acute necrotizing pancreatitis: An Eastern Association for the Surgery of Trauma modified Delphi method consensus study. The Journal of Trauma and Acute Care Surgery, 96(6), 965–970.
- "Duct tape:" Management strategies for the pancreatic anastomosis during pancreatoduodenectomy.
  Harrison, J., Dua, M. M., Kastrinakis, W. V., Fagenholz, P. J., Fernandez-Del Castillo, C., Lillemoe, K. D., … Qadan, M. (2024). "Duct tape:" Management strategies for the pancreatic anastomosis during pancreatoduodenectomy. Surgery.
- The Potential Clinical Benefits of Direct Surgical Transgastric Pancreatic Necrosectomy for Patients With Infected Necrotizing Pancreatitis.
  Timmerhuis, H. C., Ngongoni, R. F., Li, A., McGuire, S. P., Lewellen, K. A., Dua, M. M., … Visser, B. C. (2024). The Potential Clinical Benefits of Direct Surgical Transgastric Pancreatic Necrosectomy for Patients With Infected Necrotizing Pancreatitis. Pancreas, 53(7), e573–e578.
- Revascularization techniques for complete portomesenteric venous occlusion in patients undergoing pancreatic resection.
  Harrison, J. M., Li, A. Y., Bergquist, J. R., Ngongoni, F., Norton, J. A., Dua, M. M., … Visser, B. C. (2024). Revascularization techniques for complete portomesenteric venous occlusion in patients undergoing pancreatic resection. HPB : the Official Journal of the International Hepato Pancreato Biliary Association.
- Two-Port Minimally Invasive Nephro-Laparoscopic Retroperitoneal Debridement for Pancreatic Necrosis.
  Harrison, J. M., Li, A. Y., Sceats, L. A., Bergquist, J. R., Dua, M. M., & Visser, B. C. (2024). Two-Port Minimally Invasive Nephro-Laparoscopic Retroperitoneal Debridement for Pancreatic Necrosis. Journal of the American College of Surgeons.
- JAK inhibition with tofacitinib rapidly increases contractile force in human skeletal muscle.
  Shrager, J. B., Randle, R., Lee, M., Ahmed, S. S., Trope, W., Lui, N., … Tang, H. (2024). JAK inhibition with tofacitinib rapidly increases contractile force in human skeletal muscle. Life Science Alliance, 7(11).
- What's Behind it all: A Retrospective Cohort Study of Retrogastric Pancreatic Necrosis Management.
  Harrison, J. M., Day, H., Arnow, K., Ngongoni, R. F., Joseph, A., Aldridge, T., … Visser, B. C. (2024). What's Behind it all: A Retrospective Cohort Study of Retrogastric Pancreatic Necrosis Management. Annals of Surgery.
- Spatial analysis reveals targetable macrophage-mediated mechanisms of immune evasion in hepatocellular carcinoma minimal residual disease.
  Lemaitre, L., Adeniji, N., Suresh, A., Reguram, R., Zhang, J., Park, J., … Dhanasekaran, R. (2024). Spatial analysis reveals targetable macrophage-mediated mechanisms of immune evasion in hepatocellular carcinoma minimal residual disease. Nature Cancer.
- Predictors of malignant transformation in mucinous pancreatic cystic neoplasm: A systemic review and meta-analysis.
  Solis-Pazmino, P., Pazmino, C., Termeie, O., La, K., Pilatuna, E., Tite, B., … Visser, B. C. (2024). Predictors of malignant transformation in mucinous pancreatic cystic neoplasm: A systemic review and meta-analysis. Surgical Oncology, 57, 102153.
- Cholangiocarcinoma.
  Harrison, J. M., & Visser, B. C. (2024). Cholangiocarcinoma. The Surgical Clinics of North America, 104(6), 1281–1293.
- Distal Pancreatectomy with and without Celiac Axis Resection for Adenocarcinoma: A Comparison in the Era of Neoadjuvant Therapy.
  Daniel, S. K., Hironaka, C. E., Ahmad, M. U., Delitto, D., Dua, M. M., Lee, B., … Poultsides, G. A. (2024). Distal Pancreatectomy with and without Celiac Axis Resection for Adenocarcinoma: A Comparison in the Era of Neoadjuvant Therapy. Cancers, 16(20).
- Biochemical, Radiographic, or Pathologic Response to Neoadjuvant Chemotherapy in Resected Pancreatic Cancer: Which is Best?
  Ahmad, M. U., Javadi, C. S., Chang, J. D., Forgó, E., Delitto, D. J., Dua, M. M., … Poultsides, G. A. (2024). Biochemical, Radiographic, or Pathologic Response to Neoadjuvant Chemotherapy in Resected Pancreatic Cancer: Which is Best? Annals of Surgery.
- Association of Care Fragmentation and Hospital Cancer Designation with Survival in Gastroesophageal Junction Cancer: A State-Wide Study.
  Ngongoni, R. F., Timmerhuis, H. C., Li, A. Y., Day, H., Harrison, J., & Visser, B. C. (2025). Association of Care Fragmentation and Hospital Cancer Designation with Survival in Gastroesophageal Junction Cancer: A State-Wide Study. Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract, 101962.
- Care fragmentation in hepatocellular carcinoma: Opportunities to fix a broken sector.
  Harrison, J. M., Timmerhuis, H. C., Day, H., Ngongoni, R. F., Furst, A., Dua, M. M., … Visser, B. C. (2025). Care fragmentation in hepatocellular carcinoma: Opportunities to fix a broken sector. Surgery, 181, 109154.
- Letter to editor: Reframing the Fellowship Council requirements for an abdominal wall reconstruction designation.
  Lidor, A., Matthews, B., Lin, E., Doyle, M. B., Martinez, J., Kothari, S., & Visser, B. (2025). Letter to editor: Reframing the Fellowship Council requirements for an abdominal wall reconstruction designation. Surgery, 109111.
- Postoperative hepatic insufficiency despite preoperative portal vein embolization: Not just about the volumetrics.
  Li, A. Y., Ahmad, M. U., Sofilos, M. C., Lee, R. M., Maithel, S. K., Lee, T. C., … Poultsides, G. A. (2025). Postoperative hepatic insufficiency despite preoperative portal vein embolization: Not just about the volumetrics. Surgery, 182, 109345.
- Spleen Preservation in Solid Pseudopapillary Neoplasms of the Distal Pancreas: A Single-Center Experience.
  Yue, T. M., Sun, B. J., Delitto, D. J., Dua, M. M., Norton, J. A., Poultsides, G. A., … Lee, B. (2025). Spleen Preservation in Solid Pseudopapillary Neoplasms of the Distal Pancreas: A Single-Center Experience. The Journal of Surgical Research, 310, 17–21.

View More Publications

Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Open Trials Closed Trials

Study of PRRT in Metastatic, World Health Organization (WHO) Grade 1 or 2, SSTR Positive, GEP-NET Who Are Candidates for Cytoreductive Surgery

Specializing In

Practice Locations

Gastrointestinal (GI) Cancer Program in Palo Alto Palo Alto, CA

Palo Alto, CA

Gastrointestinal (GI) Cancer Program in Palo Alto

875 Blake Wilbur Dr

Palo Alto , CA 94304

(650) 498-6000

More Clinic Information

Sarcoma Program at Blake Wilbur Building Palo Alto, CA

Palo Alto, CA

Sarcoma Program at Blake Wilbur Building

875 Blake Wilbur Dr

Palo Alto , CA 94304

(650) 498-6000

More Clinic Information

Islet Cell Autotransplantation Program Redwood City, CA

Redwood City, CA

Islet Cell Autotransplantation Program

420 Broadway Street

Redwood City , CA 94063

(650) 736-5555

More Clinic Information

Important Information about Our Organizations and Physician Affiliation

Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are each independent nonprofit organizations that are affiliated with but separate from each other and from Stanford University. The physicians who provide care at facilities operated by Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are faculty, foundation, or community physicians who are not employees, representatives, or agents of Stanford Health Care, Stanford Health Care Tri- Valley, or Stanford Medicine Partners. Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners do not exercise control over the care provided by such faculty, foundation, and community physicians and are not responsible for their actions.

Patient Ratings

(54 Ratings)

Overall Rating

4.8/5

View Ratings by Category

4.9/5

Friendliness

4.8/5

Explanations

4.9/5

Listens

4.8/5

Care provider's efforts to include you in decisions about your care

4.9/5

Recommended to others

0.0/5

Wait times

How Our Ratings Work

The Patients Ratings and comments are gathered from our Patient Satisfaction Survey and displayed in their entirety.

Patient Satisfaction Survey Disclaimer

Patient Reviews

(263 reviews)

Heâ€™s a good doctor. I think heâ€™s very knowledgeable in the field.

Mar 2025

•

Verified SHC Patient

Dr. Visser is an excellent doctor, he's very knowledgeable, smart, caring, sincere and professional ! I have a lot of respect for Dr. Visser.

Feb 2025

•

Verified SHC Patient

Professional, answered questions, crisp.

Feb 2025

•

Verified SHC Patient

Dr. Visser is a stellar surgeon of GI Oncology. He is extremely efficient and has always explained to me treatment options very well. He goes above and beyond during video calls showing and describing the scan images. I personally find this an excellent way of communication. And he is very accommodating with in-person and video consultations schedules specially since it takes me a good three plus hours each way from Roseville to Palo Alto. Thank you Dr. Visser!!

Feb 2025

•

Verified SHC Patient

I have been very happy to work with Dr. VIsser. He explains things well and gives me confidence in my hoped for outcome.

Feb 2025

•

Verified SHC Patient

Doctor Visser and his team are fantastic

Feb 2025

•

Verified SHC Patient

He is awesome.

Feb 2025

•

Verified SHC Patient

Looking forward to surgery with him and his team.

Jan 2025

•

Verified SHC Patient

Excellent Doctor explains everything so you understand it.

Jan 2025

•

Verified SHC Patient

Excellent surgeon.

Jan 2025

•

Verified SHC Patient

Thorough.. attentive

Dec 2024

•

Verified SHC Patient

Dr Visser came to meeting well prepared and, despite the nature of the evaluation for my health condition, made every effort to give me a fair evaluation of the circumstances for my future condition.

Dec 2024

•

Verified SHC Patient

Thank you for letting me know i can use Ozempic and that there is no problem using it because of my surgery and having to have a progress thank you for saving my life by taking this tumor that was growing, even though it was a cancer thank you once again

Nov 2024

•

Verified SHC Patient

Dr. Visser took the time to answer all my questions. He was very detailed and helpful in his explanation of my options.

Nov 2024

•

Verified SHC Patient

Very professional and informative. Very comfortable with his recommendation.

Oct 2024

•

Verified SHC Patient

He's awesome!

Sep 2024

•

Verified SHC Patient

Dr. Visser was excellent throughout my surgery and aftercare.

Aug 2024

•

Verified SHC Patient

Heâ€™s an excellent physician, very knowledgeable and caring too. Heâ€™s an asset to Standford!

Jun 2024

•

Verified SHC Patient

He is extremely intelligent and skilled, and is saving many lives including mine. I am very grateful for him. When I think of Dr. Visser, I think of the word â€œexcellence.â€

Jun 2024

•

Verified SHC Patient

Iâ€™ve been seeing Dr Visser for 13 years and have the upmost confidence in him

Apr 2024

•

Verified SHC Patient

I've really enjoyed working with him, absolutely trust his expertise. I think... I feel well cared for. Would recommend him in a millisecond, and if I ever need active treatment/intervention he's my first choice.

Apr 2024

•

Verified SHC Patient

Thanks!

Apr 2024

•

Verified SHC Patient

He is know as the best in his field and am happy heâ€™s my surgeon.

Mar 2024

•

Verified SHC Patient

He is the GREATEST, and his residents, fellow and staff, also

Mar 2024

•

Verified SHC Patient

Dr. Brendan Visser in one sentence went above and beyond on Feb 13th trying to make the most of my appointment with him in spite of all the IT related technical glitches. Throughout the entire call I could not see him but only hear him. He tried his best to educate me and show me relevant images via computer sharing, moving more than once to two different offices but nothing worked. I truly appreciate Dr. Visser's efforts given his busy schedule and the additional time spent with me. He was succinct in his explanation of my condition and why his proposed treatment the most optimal. I am trying to get another video appointment with him to further discuss my case and proceed with the treatment plan he has for me. Thank you Dr. Visser!!

Feb 2024

•

Verified SHC Patient

Dr Visser is an absolute blessing to Stanford Hospital and to any one that has him as a doctor, he's caring, friendly, trustworthy, very professional, and very very knowledgeable. I would and have referred other's to him.

Feb 2024

•

Verified SHC Patient

Took the time to carefully explain everything.

Feb 2024

•

Verified SHC Patient

Dr. Visser is the most outstanding surgeon. I owe my life to him. Due to his expertise and clinical acumen he has guided my therapy from a dire situation to one with hope. He is not only an expert professionally but he is kind and compassionate. He communicates clearly, succinctly and answers all of our questions.

Jan 2024

•

Verified SHC Patient

He is an excellent doctor, and am very confident with him. He is the best.

Jan 2024

•

Verified SHC Patient

Wonderful doctor, very knowledgeable and professional. I'm thankful he was my doctor.

Jan 2024

•

Verified SHC Patient

Dr V was on time for the appointment. I did not have to wait long which is extremely important to me.

Dec 2023

•

Verified SHC Patient

very straightforward, professional and answered all my questions.

Dec 2023

•

Verified SHC Patient

Dr. Visser appears to me to be an outstanding physician who does not look at medical conditions with a one size fits all approach. I understand what he is saying from a biological/physiological/medical point of view and appreciate his approach to the point that I am staking my life on his advice.

Dec 2023

•

Verified SHC Patient

Dr. Visser is the best! He truly cares about me, my health and social life. I know my condition is in the best hands on this entire earth. Dr. Visser is an amazing man and I consider a friend for life. Not that we hang out for coffee but he is a dear friend in my book.

Dec 2023

•

Verified SHC Patient

Brendon Visser was good doctor

Nov 2023

•

Verified SHC Patient

He has been a wonderful help to me over the last 5+ years. I am thankful for his skills and attention to my health issues.

Nov 2023

•

Verified SHC Patient

Dr Visser was thorough and it appeared he had reviewed my records and had a clear picture of my overall health.

Oct 2023

•

Verified SHC Patient

Very good options

Oct 2023

•

Verified SHC Patient

Dr. Visser is an excellent surgeon. He is exceptional and a leader in his field. His expertise and clinical acumen is quite apparent. As a patient, I trust him without reservation. He clearly communicates his findings and recommendations. He is compassionate and kind.

Oct 2023

•

Verified SHC Patient

He was great, explained everything and answered all our questions.

Oct 2023

•

Verified SHC Patient

He is extremely knowledgeable and am extremely grateful that I was referred to him. I couldnâ€™t ask for more. He was the only doctor that gave me hope.

Oct 2023

•

Verified SHC Patient

He was very clear about treatment plan. He spoke in terms we could understand and had a positive attitude.

Sep 2023

•

Verified SHC Patient

Dr. Visser is an excellent surgeon. He explains clearly his findings and what his recommendations are. His clinical acumen is very apparent which engenders trust. He is kind and compassionate.

Sep 2023

•

Verified SHC Patient

Dr. Visser is an excellent surgeon, world renown in his field. I feel very privileged to have him as my doctor and trust his clinical acumen, surgical skills, and judgement. He communicates clearly and shows empathy for his patients. He is simply exceptional.

Sep 2023

•

Verified SHC Patient

I am lucky to have had him as my surgeon.

Aug 2023

•

Verified SHC Patient

Dr. Visser is a very good cancer doctor and a fantastic surgeon. He has done a few very specialized and difficult surgerys and I am thankful for the opportunity to be a patient of his.

Aug 2023

•

Verified SHC Patient

Dr. Visser is a very professional and knowledgeable doctor. I have great confidence in him taking care of me.

Aug 2023

•

Verified SHC Patient

I have an extremely high confidence level in Dr. Visser. I am staking my life on his professional opinion and advice.

Jul 2023

•

Verified SHC Patient

He is the Best!

Jul 2023

•

Verified SHC Patient

Dr. Visser is the most attentive and caring physician we know. He allows a person to know they are valuable, and his function in the medical field, is the best and highly known. We love this man and thank God for him also.

Jul 2023

•

Verified SHC Patient

Thank you for giving me the opportunity to have the video visit.

Jul 2023

•

Verified SHC Patient

He is an excellent physician. He is very knowledgeable and provides compassionate care to his patients. He is an asset to Stanford.

Jun 2023

•

Verified SHC Patient

Thank you for your care

Jun 2023

•

Verified SHC Patient

Dr. Visser is a superb surgeon, excellent doctor, and an overall nice person. I would highly recommend him to everyone.

May 2023

•

Verified SHC Patient

Excellence!!!

May 2023

•

Verified SHC Patient

Excellence

May 2023

•

Verified SHC Patient

Thank you!

May 2023

•

Verified SHC Patient

Dr. Visser is everything I would want in a surgeon who deals with life or death surgical issues. Dr. Visser is direct, patient, informative, and has given me the data and benefit of his experience necessary for me to make an informed decision as to my treatment for my condition.. He answered my questions directly, and did not approach me telling me what he thought he wanted me to hear; he was forthright in explaining the risk/benefit analysis of my situation. Dr. Visser personifies why I only have sought care from a top tier academic medical center for my previous four cancers, as well as for other serious medical conditions. Dr. Visser's experience, training, and competence is why I sought his opinion as to the prognosis and best approach to my medical condition. In the final analysis I trust him.

Apr 2023

•

Verified SHC Patient

I think he is very straightforward and to the point. I like him.

Apr 2023

•

Verified SHC Patient

Dr. Visser's advice to me and approach to my situation was of tremendous value to me, and I appreciated his directness in his advice to me regarding my particular illness as I went in to my appointment with him having total confidence that I was going to have a consultation with a surgeon recognized as being at the top echelon of his field. I have been around for a long time, and have had a dozen surgeries in my life, five for cancer, and I always have appreciated a surgeon who would give me the data that I need to make, when taken together with his/her advice, an informed decision as to how I should proceed, especially when we are dealing with cancer. Dr. Visser took th time not only to explain to me the direction I should consider taking, and the risks involved, but also the analysis based on his experience considering my particular situation that formed the basis of his opinion. Dr. Visser personifies why I seek care at an academic medical center like Stanford when issues are complicated, as opposed to local medical facilities. Having sat on this information for a few days, I am comfortable in proceeding with Dr. Visser's suggestions as to how I might wish to proceed in the immediate future, as opposed to rushing into a complicated life changing surgery before doing so is, in the final analysis, necessary to prolong my life. I appreciate all that.

Apr 2023

•

Verified SHC Patient

I believe he is an excellent physician, who cares about his patients and I consider him to be excellent in his field. Have shared it with others about his excellence in his field and his demeanor, is great with his patients.

Apr 2023

•

Verified SHC Patient

Dr. Visser is a great physician. He is very knowledgeable and answered all my questions.

Feb 2023

•

Verified SHC Patient

Dr. Visser has been professional, informative, supportive and kind. I appreciate how he explained my diagnosis, type of surgery (no other treatment options), what to expect during surgery, recovery and future treatment. He did a fantastic job removing the Gastrointestinal Stromal Tumors and Lymph nodes in and around my stomach. If my cancer returns, I feel confident Dr. Visser will remove it successfully.

Feb 2023

•

Verified SHC Patient

Dr Visser is a wonderful caring doctor, always very professional and he's very knowledgeable. I have complete confidence in him and he always demostrates that he cares about the patient and he's very tenative to the patient.

Feb 2023

•

Verified SHC Patient

Vesser saved my life

Feb 2023

•

Verified SHC Patient

Excellent Dr,

Jan 2023

•

Verified SHC Patient

Dr. Visser is amazing! He is caring, considerate, and has the ability to explain what needs to happen and what has happened in detail that is easy to understand! His entire time is excellent, and I could not be happier with the care I have received!

Jan 2023

•

Verified SHC Patient

highly recommended;

Nov 2022

•

Verified SHC Patient

Excellent surgeon! Enjoy working with him!

Nov 2022

•

Verified SHC Patient

Dr. Visser is an excellent doctor. He is capable, thorough and truly cares about his patients. His expertise is very apparent. Glad to have him as my doctor.

Nov 2022

•

Verified SHC Patient

El Doctor Viseer hizo muy buen trabajo gracias

Oct 2022

•

Verified SHC Patient

Dr Visser was very pleasant & professional on the video call.

Oct 2022

•

Verified SHC Patient

Dr.Visser's comments were comprehensive, from technical aspects of surgery to reasons for it and its alternative. Very rate!

Oct 2022

•

Verified SHC Patient

very good Dr. Gave me different options.

Oct 2022

•

Verified SHC Patient

Dr Visser explain me very well I am glad that my G.I. doctor sent me there.thank you

Sep 2022

•

Verified SHC Patient

Dr. Visser is an exceptional surgeon, thorough, competent, excellent clinical acumen. I owe my life to him.

Sep 2022

•

Verified SHC Patient

Dr. Vissar saved my life. He is caring, talented and does not give up. He is a remarkable surgeon and doctor.

Sep 2022

•

Verified SHC Patient

Doctor Brendan Visser is a very professional Doctor.

Aug 2022

•

Verified SHC Patient

Dr. Visser was compassionate, experienced and personable.

Jul 2022

•

Verified SHC Patient

He was great!!

Jul 2022

•

Verified SHC Patient

So very personable and made me feel at ease.

Jul 2022

•

Verified SHC Patient

Well prepared and knowledgeable.

Jul 2022

•

Verified SHC Patient

we highly respect him and would recommend him to anyone in need. excellent doctor.

Jul 2022

•

Verified SHC Patient

without him I would be died

Jun 2022

•

Verified SHC Patient

Very professional, thorough, answered all questions, informative, helpful.

Jun 2022

•

Verified SHC Patient

I was glad of the outcome ,but because there was no hands on exam I felt like it could of been a phone Consut Dr. V was very nice bjt seemed in a hurry. At 6.00$ A GALLON AND A TWO HR. DRIVE . I NEEDED MORE TIME FOR QUESTIONS. I

Jun 2022

•

Verified SHC Patient

Dr Brendan Visser is an excellent physician who really cares genuinely to his patients. He is very knowledgeable and is very professional. Iâ€™m so lucky to have him as my oncology surgeon .

Jun 2022

•

Verified SHC Patient

Dr Vissar is the best!

Jun 2022

•

Verified SHC Patient

He is clearly a busy guy, but besides being a great surgeon, communicates well and warmly, while being clear about what he wants the patient to know.

Jun 2022

•

Verified SHC Patient

Great communication, skilled, listens.

May 2022

•

Verified SHC Patient

Competent, involved and knowledgeable MD.

May 2022

•

Verified SHC Patient

Thorough, informative and conpassionate

May 2022

•

Verified SHC Patient

Amazing, talented, compassionate Surgeon and person.

May 2022

•

Verified SHC Patient

The best

May 2022

•

Verified SHC Patient

Dr. Visser provided excellent care and responded directly to my questions. He quickly pulled up anything from my records that applied to our conversation. The session was divided into a prep portion with a resident and a few minutes later the session with Dr. Visser. I am completely comfortable with this approach. His whole surgical team was very professional and actually fun to work with through the entire process. The result was all I could have hoped for!

Apr 2022

•

Verified SHC Patient

Dr. Visser is an exceptional physician, thorough, excellent communicator.

Apr 2022

•

Verified SHC Patient

Great

Apr 2022

•

Verified SHC Patient

Dr. VIisser and his team were stellar. We are choosing to travel 300 miles to habe him perform my surgery because he offered state of the art surgery that is not available in my area. His team took time to thoroughly understand my needs and carefully explain my surgery and care.explain

Apr 2022

•

Verified SHC Patient

Amazing

Apr 2022

•

Verified SHC Patient

Great appointment.

Mar 2022

•

Verified SHC Patient

Dr Vissar is an honest caring doctor. I have full confidence in him for my care.

Mar 2022

•

Verified SHC Patient

Excellent surgeon!

Mar 2022

•

Verified SHC Patient

I'm extremely pleased w/Dr. Visser' professionalism and knowledge of my hereditary colon cancer syndrome. It's an honor to be under his care and watchful eye. Due to the complexity of my syndrome I'll be under his care for years to come. His bed side manners are absolutely amazing.

Mar 2022

•

Verified SHC Patient

I was treated with all friendly people. Very efficient!

Mar 2022

•

Verified SHC Patient

Great physician! Friendly and extremely competent

Mar 2022

•

Verified SHC Patient

great MD - I am in the right place.

Mar 2022

•

Verified SHC Patient

Dr Visser is amazing. Thorough and very good listener!

Mar 2022

•

Verified SHC Patient

I appreciate and recommend for his professional medical career.

Feb 2022

•

Verified SHC Patient

Dr. Visser was very helpful and professional throughout my whole ordeal I would highly recommend him to anybody who needs his help I Believe if it wasnâ€™t for Dr. Visser I would not be here today

Feb 2022

•

Verified SHC Patient

Excellent

Feb 2022

•

Verified SHC Patient

Professional, competent, empathic, humble. Last August 2021, I lost control of my vehicle and blacked out. I was faced with a massive, life threatening, unexplained intra-abdominal bleeding and underwent emergency surgery. As a physician I consulted from my Nevada hospital bed with many institutions, friends, and colleagues to help solve this mystery across states and continents. The hospital transfer to Stanford was difficult in the midst of a covid surge, hospital beds available were scarce. Several institutions and specialty services rejected requests for advice and transfer. Dr. Brendan Visser of the surgical oncology service took on my case. Ultimately there is still no exact certainty about what happened and this episode will remain a medical mystery. Thankfully I recovered and am in excellent health. I will never forget and remain extremely grateful for the courtesy and care extended to me by Dr. Brendan Visser and his team at Stanford.

Feb 2022

•

Verified SHC Patient

The visit was detailed to the point where I understand what I wanted to know.

Feb 2022

•

Verified SHC Patient

Very informative visit and gave me great confidence that I fully understand what will happen next. The risks are worth the potential personal gain. I am ready to go.

Jan 2022

•

Verified SHC Patient

Very thoughtful Dr

Dec 2021

•

Verified SHC Patient

He convinced me I will live under his care.

Dec 2021

•

Verified SHC Patient

THANKS

Dec 2021

•

Verified SHC Patient

Everything was explained to me to my satisfaction. Very professional team.

Dec 2021

•

Verified SHC Patient

I appreciated that Dr. Visser was candid, upfront and to the point concerning my medical situation.

Dec 2021

•

Verified SHC Patient

Excellent caring physician

Dec 2021

•

Verified SHC Patient

Provide reassurance and responded well to all my questions and concerns!

Nov 2021

•

Verified SHC Patient

I am extremely pleased with Dr Visser and his care team. He and everyone on the team are caring, responsive to questions, easily accessible and put me at ease when I felt apprehensive about the condition and my care.

Nov 2021

•

Verified SHC Patient

THANK YOU!!

Nov 2021

•

Verified SHC Patient

He was fully focused snd present.

Oct 2021

•

Verified SHC Patient

Very nice and helpful

Oct 2021

•

Verified SHC Patient

Very dedicated to my situation.

Oct 2021

•

Verified SHC Patient

Excellent, outstanding doctor

Oct 2021

•

Verified SHC Patient

He made me feel very comfortable with his expertise and diagnosis. He is very friendly and even funny in a very stressful time.

Oct 2021

•

Verified SHC Patient

He is an excellent doctor

Sep 2021

•

Verified SHC Patient

All positive impressions. Dr. Visser and his care team are all responsive and thorough.

May 2021

•

Verified SHC Patient

Dr Visser is the best, always informative and addressing all issues after the surgery

May 2021

•

Verified SHC Patient

Knowledgeable, Forthright, Personable, Caring.

May 2021

•

Verified SHC Patient

Dr. Visser and everyone there are so considerate and nice. Since the start of my visits there and in the hospital before and after my surgery it has been excellent.

Feb 2021

•

Verified SHC Patient

Excellent doctor. His knowledge was comforting & explained everything very well.

Feb 2021

•

Verified SHC Patient

Good.

Jan 2021

•

Verified SHC Patient

Very good.

Jan 2021

•

Verified SHC Patient

Excellent provider.

Jan 2021

•

Verified SHC Patient

Helped me understand my situation.

Jan 2021

•

Verified SHC Patient

Dr. Visser is the best!! And his PA.

Dec 2020

•

Verified SHC Patient

My son accompany me when I have doctor visits, and as I known, he had refer 2-3 of his friends to visit Dr. Brendan Visser. They are very satisfy.

Dec 2020

•

Verified SHC Patient

My experience was that I was very serious thanks to Doctor Visser the attention he gave me I am alive to talk about it.

Nov 2020

•

Verified SHC Patient

Dr. Visser is an excellent doctor. He is highly knowledgeable and skilled. I would hope to never have a major surgery need in the future but if I did... Dr. Visser would hopefully be available to me!

Nov 2020

•

Verified SHC Patient

Couldn't say enough for excellent care Dr. Visser has given me.

Oct 2020

•

Verified SHC Patient

Dr. Visser and associate Dr. Josh - Nothing short of outstanding.

Jul 2020

•

Verified SHC Patient

Dr. Visser is wonderful and caring. I am fortunate to have him for my physician.

Jun 2020

•

Verified SHC Patient

Dr. Vesser spent a long time with me - nearly on hour. He was terrific. I do not know if he could have spent as much time but for COVID-19.

Jun 2020

•

Verified SHC Patient

Great staff.

Apr 2020

•

Verified SHC Patient

Excellent professional visit for a tough problem.

Apr 2020

•

Verified SHC Patient

Doctor is very knowledgeable, explained the problem clearly. One of best doctors.

Mar 2020

•

Verified SHC Patient

Dr. Visser is exceptional, very thorough, very caring and the best.

Jan 2020

•

Verified SHC Patient

First comes into room and states rather abruptly I don't like your pulmonary function.

Jan 2020

•

Verified SHC Patient

Utmost trust in Dr. Visser. Couldn't have a BETTER doctor.

Dec 2019

•

Verified SHC Patient

Dr Visser saver my life!

Dec 2019

•

Verified SHC Patient

When I asked about my CT scan, I was told not to worry about it. He said the other doctors do not know how to read them. He asked me if I had any questions. I asked him about one of the things that was on the CT scan and again he told me that the person that wrote about what they saw on the scan did not know how to read it. He never explained why. I left wondering why three other doctors, that do not know each other came up with the same conclusion. I tried to tell him that something else is going on but he said that everything is good with me and not to worry. That is hard to do when I am feeling sick.

Dec 2019

•

Verified SHC Patient

Drs. were knowledgeable and explained things well. The only negative aspect was that Dr. Visser was continually paged and had to take a phone call during my appointment.

Dec 2019

•

Verified SHC Patient

good

Dec 2019

•

Verified SHC Patient

Dr. Visser explains everything and cares very much.

Dec 2019

•

Verified SHC Patient

Dr. Visser was EXCELLENT in every way.

Dec 2019

•

Verified SHC Patient

Dr. Visser is clearly an expert in his field, and he was honest and straightforward with me about not knowing what kind of mass I had, despite that being difficult news. He & his staff recognized that they could help me sooner rather than later & worked to make that happen.

Oct 2019

•

Verified SHC Patient

I am in good hands. Am very happy I came to Stanford.

Oct 2019

•

Verified SHC Patient

They rush in late & rush out immediately... having someone else come in... very unorganized or lack of communication.

Sep 2019

•

Verified SHC Patient

Very good.

Sep 2019

•

Verified SHC Patient

Quality of care at Stanford has been outstanding.

Sep 2019

•

Verified SHC Patient

Dr. Visser is a caring, excellent physician who is an asset to your hospital. He is very knowledgeable & is very professional in dealing with his patients. I am so blessed to have him as my surgeon/oncologist.

Sep 2019

•

Verified SHC Patient

on this particular visit I felt the Dr. Visser was rushed and not fully engaged with me.

Sep 2019

•

Verified SHC Patient

Excellence!

Aug 2019

•

Verified SHC Patient

Was final follow-up visit. Dr. Visser has been a "life saver." A pleasure to have been his patient.

Aug 2019

•

Verified SHC Patient

Excellent physicians & NP. Very detailed and compassionate and concerned about getting me immediate care. Also called me at home to keep me updated.

Jun 2019

•

Verified SHC Patient

Dr. Visser and his PA (Kristen?) were personable and professional to a fault. I couldn't have asked for a better care team.

Jun 2019

•

Verified SHC Patient

I am very confident in Dr. Visser and his team of experts.

Jun 2019

•

Verified SHC Patient

Dr. Visser & Dr. Basina are the best in there fields worth my having to drive 50 miles to see them.

May 2019

•

Verified SHC Patient

Dr. Visser and Kristen Wheeler were exceptionally helpful and articulate in explaining my symptoms and procedure needed.

May 2019

•

Verified SHC Patient

Excellent experience at all my appointments and treatment.

May 2019

•

Verified SHC Patient

Dr. Visser and his team are excellent! They are very knowledgeable and explain everything to me in a way that I can understand fully.

Apr 2019

•

Verified SHC Patient

I can always depend on Dr Visser and his team are there for me with the answers and corrective action

Mar 2019

•

Verified SHC Patient

Dr. Visser, Kristan Wheeler, Taylor Foyel, Monica Dua and all of Dr. Visser staff were very kind and friendly! Best office experience I ever had.

Mar 2019

•

Verified SHC Patient

Dr, Visser did not share any information I did not know. Did not offer any recommendation other than surgery as expected. More in depth analysis of my unique condition would have been helpful. Statistics in probability of progression on my pancreatic NET was missing.

Feb 2019

•

Verified SHC Patient

I think that Stanford Health Care is the best we have in California all excellent.

Feb 2019

•

Verified SHC Patient

great. great. great wonderful doctor

Feb 2019

•

Verified SHC Patient

Dr. Visser was AMAZING!!

Feb 2019

•

Verified SHC Patient

Everyone was nice and caring and made me comfortable and understand about my physical condition. Dr. Visser is good and knowledgeable person. I would highly recommend to others.

Jan 2019

•

Verified SHC Patient

I feel blessed that Dr. Visser took me in as a patient. he has been working to correct damage implemented by a previous hospital. I am not sure where my health would have ended up without his expertise - Very grateful.

Jan 2019

•

Verified SHC Patient

Dr. Visser was amazing. He answered all our questions & concerns... He was very kind. His PA that saw us the first day was amazing helped with drsg. D & skin.

Dec 2018

•

Verified SHC Patient

I am still confused about the information from the consultation, and I can't find a way to get questions answered. I think Dr. Visser is an excellent surgeon, but I will probably either cancel or delay the surgery. Also, if they won't respond to phone calls now, and I had a problem after surgery, would they respond them? Maybe not.

Dec 2018

•

Verified SHC Patient

Dr Visser had review my case before entering the exam room. He put me at ease and instilled confidence that he is competent and knowledgeable surgeon.

Oct 2018

•

Verified SHC Patient

Very good.

Oct 2018

•

Verified SHC Patient

Post surgery, this was my 4th year meeting with Dr. Vissor. We always have a lively discussion. He help save my life in a big way!

Aug 2018

•

Verified SHC Patient

Dr. Visser inspires confidence.

Jul 2018

•

Verified SHC Patient

Dr. Visser is an asset to Stanford Health Care. He is an excellent physician with good bedside manner. Very professional, knowledgeable and very compassionate. I am so lucky to have him as my onco/surgeon. He saved my life!

Jul 2018

•

Verified SHC Patient

excellent

Jul 2018

•

Verified SHC Patient

excellent

Jun 2018

•

Verified SHC Patient

I like Dr Visser & his assist, overall, good experience.

Jun 2018

•

Verified SHC Patient

Could not have been a better experience totally being treated by Dr. Visser and his PAs Kristen and Tanya.

May 2018

•

Verified SHC Patient

I am cancer free and alive today because of Dr. Visser. the only doctor after seeing so many who diagnosed my cancer and had the capability of performing my surgery

May 2018

•

Verified SHC Patient

good

May 2018

•

Verified SHC Patient

There was some use of medical jargon for which I had to stop the provider and ask for a clarification.

May 2018

•

Verified SHC Patient

Dr. Visser great clinician!

May 2018

•

Verified SHC Patient

Excellent! Thank you!

Mar 2018

•

Verified SHC Patient

This was just a short follow - up, that gave me confidence in my body's healing. Dr. Visser is a terrific physician & relates well to the patient.

Jan 2018

•

Verified SHC Patient

All good.

Jan 2018

•

Verified SHC Patient

care provider very easy to understand and very thorough

Jan 2018

•

Verified SHC Patient

Excellent experience!

Jan 2018

•

Verified SHC Patient

Surgeon was highly recommended to me by oncologist at PAMF. Nothing in subsequent appointments w/this doctor altered my impression of this surgeon.

Dec 2017

•

Verified SHC Patient

I have total confidence in Dr. Visser. If I were asked where I wanted to go if I had to go the hospital; it would be Stanford.

Dec 2017

•

Verified SHC Patient

My high marks are made without reservation. I cannot imagine better care from all levels. Thank you.

Oct 2017

•

Verified SHC Patient

Always was put a ease. All test results were carefully explained. I always felt very good after each visit.

Oct 2017

•

Verified SHC Patient

the information was both refreshing and a bit daunting as I have a rare problem and the surgeon recommended a second surgery to deal with the problem.

Sep 2017

•

Verified SHC Patient

PA went over CT scans with us & explained very clearly.

Aug 2017

•

Verified SHC Patient

Provider was just wonderful

Jul 2017

•

Verified SHC Patient

Actual time spent with Dr. Visser helpful! Good explanations & answered all questions satisfactorily.

Jul 2017

•

Verified SHC Patient

Thank you again!

Jun 2017

•

Verified SHC Patient

no bad experience

Jun 2017

•

Verified SHC Patient

I will gladly recommend both Dr. Visser and Dr. Heestand and their PA to Friends and Family

Mar 2017

•

Verified SHC Patient

World's best doctor thank God for him.

Mar 2017

•

Verified SHC Patient

Doctor was a bit distant, hurried, not engaged with me as an individual (but, not unusual for a surgeon).

Jan 2017

•

Verified SHC Patient

Dr. Visser explained very clearly & answered all questions we had.

Jan 2017

•

Verified SHC Patient

Always the best of care.

Jan 2017

•

Verified SHC Patient

Dr Visser is a very nice man who can come down to your level and explain to you what he thinks. He is very good at being honest and providing you with any choice there may be. I liked his style very much. He knows people come to see him and they are nervous I believe Dr Visser realizes this and shows care and kindness yet he does give you the feeling he is very confidant but in a good way NOT an arrogant way.

Jan 2017

•

Verified SHC Patient

Dr. Visser impresses me with his knowledge and expertise in his field. He makes me feel very comfortable and at easy when talking to him about my condition. He tends to explain things in easy to underst terms without feeling you are being talked down to.

Nov 2016

•

Verified SHC Patient

Dr. Visser & his staff are awesome!

Oct 2016

•

Verified SHC Patient

I consider Dr. Visser to be highly capable and kind. He has my utmost respect.

Oct 2016

•

Verified SHC Patient

Dr. Visser carefully listened to my questions and gave complete and thoughtful answers.

Oct 2016

•

Verified SHC Patient

Good experience.

Oct 2016

•

Verified SHC Patient

Dr. Visser explained everything.

Sep 2016

•

Verified SHC Patient

All are special, make me feel very good.

Jul 2016

•

Verified SHC Patient

excellent!!!!

Jul 2016

•

Verified SHC Patient

Dr. Visser listened carefully, explained what was going to happen in my surgery, and answered every question I asked.

Jun 2016

•

Verified SHC Patient

Dr. Visser is the best!! Exceeds expectations! Friendly, knowledgeable, concerned. I tell everyone how wonderful he is.

Apr 2016

•

Verified SHC Patient

All the doctors and nurses and people from the office and they are very friendly and attentive.

Apr 2016

•

Verified SHC Patient

I feel very lucky to have Dr Visser and his staff as my health providers for my recent surgery.

Apr 2016

•

Verified SHC Patient

I dont have any words to explain the level of care that my doctor has provided me. Its top notch..five star.

Apr 2016

•

Verified SHC Patient

Dr. Visser saved my life. I went months of tests surgical procedures at Sutter Medical and not one doctor knew what was wrong. I had a death sentence until I found Dr. Visser.

Mar 2016

•

Verified SHC Patient

I feel that I am in very competent hands and could not ask for more.

Feb 2016

•

Verified SHC Patient

Dr. Visser highly experienced doctor. Very courteous, politeness, friendliness. I never see doctor like dr. Visser in my life. God will give long life.

Jan 2016

•

Verified SHC Patient

Excellence.

Jan 2016

•

Verified SHC Patient

Good

Nov 2015

•

Verified SHC Patient

Dr. Visser was the first professional after seeing many doctors that came in and told me exactly what my health issue was and how to proceed. He explained every detail of what needed to be done leading up to my surgery in preparation to the details of the surgery. Dr. Visser takes his time and explains everything in a way that a person who is not a doctor can understand. he cares about his patients and his work.

Oct 2015

•

Verified SHC Patient

I get respect and kindness there.

Aug 2015

•

Verified SHC Patient

My husband and I felt like members of the treatment team and that we participated in determining the treatment plan. I wasn't told, this is what we are going to do.

Jul 2015

•

Verified SHC Patient

Excellent.

Jul 2015

•

Verified SHC Patient

Dr. Visser & Dr. Kunz were prepared, direct and knowledgeable. Excellent experience.

Jun 2015

•

Verified SHC Patient

Good experience in everything.

Jun 2015

•

Verified SHC Patient

Highly recommend Dr. Visser to any friends/family.

Jun 2015

•

Verified SHC Patient

Dr. Visser is the best!!! I completely trust him.

May 2015

•

Verified SHC Patient

I was more relaxed after speaking with the doctor.

Apr 2015

•

Verified SHC Patient

Provider was very knowledgeable and answered all questions.

Mar 2015

•

Verified SHC Patient

Both the NP & Dr. Visser were very thorough & made me feel comfortable.

Mar 2015

•

Verified SHC Patient

Outstanding.

Mar 2015

•

Verified SHC Patient

Visser is an outstanding surgeon! Never had to take pain medications.

Feb 2015

•

Verified SHC Patient

Excellent saved my life.

Jan 2015

•

Verified SHC Patient

Dr. Visser was excellent. Worth waiting for.

Nov 2014

•

Verified SHC Patient

Good care was provided.

Oct 2014

•

Verified SHC Patient

I consulted w/Dr. Visser briefly for a second opinion; he was professional - but brief - I decided to go elsewhere for my care -

Sep 2014

•

Verified SHC Patient

He is very knowledgeable, very personable & confidence puts you @ ease. Might be helpful to check in with patient before or after surgery.

Aug 2014

•

Verified SHC Patient

All good.

Jul 2014

•

Verified SHC Patient

I feel as if I am in great hands with Dr. Visser.

Jul 2014

•

Verified SHC Patient

Dr. Visser & his PA and all are Life savers and awesome.

Jul 2014

•

Verified SHC Patient

PA was very good. Vissar is great once he arrived.

Jun 2014

•

Verified SHC Patient

I appreciate my care provider, Dr. Brendan Visser. The way I look at him, he is sincere, kind and understanding.

May 2014

•

Verified SHC Patient

Dr Visser was so good, friendly knowledgeable and reassuring.

May 2014

•

Verified SHC Patient

I am not sure how I feel about this provider. I have had less than 15 minutes of interaction with them it is hard to determine how I feel.

May 2014

•

Verified SHC Patient

My experience was comfortable with the provider & his staff.

Mar 2014

•

Verified SHC Patient

Great dr. I will recommend.

Jan 2014

•

Verified SHC Patient

Great doctor! Given encouragements & hope which are importance during difficult time & recovery.

Jan 2014

•

Verified SHC Patient

View More Patient Reviews

Referring Physicians

PHYSICIAN HELPLINE

Phone: 1-866-742-4811
Fax: 650-320-9443
Monday–Friday, 8 a.m.–5 p.m.

Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referral Information.

You may also submit a web referral or complete a referral form and fax it to 650-320-9443 or email the Referral Center at ReferralCenter@stanfordhealthcare.org.

Send referrals online
Place radiology and lab orders
View referral status
Access medical records

Learn More About MedLink

LOG INTO MEDLINK

New to MyHealth?

ALREADY HAVE AN ACCESS CODE?

DON'T HAVE AN ACCESS CODE?

NEED MORE DETAILS?

MyHealth for Mobile

Brendan C. Visser, MD

Hepatobiliary surgeon, Pancreatic surgeon, Surgeon

Get In Touch

Biography

Professional Summary

Education & Certifications

Honors & Awards

Memberships

Administrative Appointments

Publications

Clinical Trials

Specializing In

Practice Locations

Gastrointestinal (GI) Cancer Program in Palo Alto Palo Alto, CA

Gastrointestinal (GI) Cancer Program in Palo Alto

Sarcoma Program at Blake Wilbur Building Palo Alto, CA

Sarcoma Program at Blake Wilbur Building

Islet Cell Autotransplantation Program Redwood City, CA

Islet Cell Autotransplantation Program

Important Information about Our Organizations and Physician Affiliation

Patient Ratings

How Our Ratings Work

Patient Reviews

(263 reviews)

Referring Physicians

PHYSICIAN HELPLINE

New to MyHealth?

ALREADY HAVE AN ACCESS CODE?

DON'T HAVE AN ACCESS CODE?

NEED MORE DETAILS?

MyHealth for Mobile

WELCOME BACK

Brendan C. Visser, MD

Hepatobiliary surgeon, Pancreatic surgeon, Surgeon

Get In Touch

Biography

Professional Summary

Education & Certifications

Honors & Awards

Memberships

Administrative Appointments

Publications

Clinical Trials

Specializing In

Practice Locations

Gastrointestinal (GI) Cancer Program in Palo Alto Palo Alto, CA

Gastrointestinal (GI) Cancer Program in Palo Alto

Sarcoma Program at Blake Wilbur Building Palo Alto, CA

Sarcoma Program at Blake Wilbur Building

Islet Cell Autotransplantation Program Redwood City, CA

Islet Cell Autotransplantation Program

Important Information about Our Organizations and Physician Affiliation

Patient Ratings

How Our Ratings Work

Patient Reviews

(263 reviews)

Referring Physicians

PHYSICIAN HELPLINE